SlideShare a Scribd company logo
22-04-2018
Leukemia and lymphoma
TONY SCARIA
2010 KMC
Leukemoid reaction
• Persistent leucocytosis above 50000 cells /mm3
• Major causes
• a/c severe infections
• Severe haemorrhages
• a/c hemolysis
• Malignancies
• Downs syndrome
• Asplenia
• DKA
TONY SCARIA
2010 KMC
22-04-2018
TONY SCARIA
2010 KMC
TONY SCARIA
2010 KMC
22-04-2018
• Immature forms present
• Early mature neutrophils are seen in leukemoid reaction
• Immature forms typically seen in CML
• LAP score is elevated in leukemoid reaction
• Depressed in CML
• No orgnaomegaly
• Organomegaly + in CML
• Basophilia eosinophilia thrombocytosis
• In CML
• Absent in leukemoid reactionsTONY SCARIA
2010 KMC
TONY SCARIA
2010 KMC
22-04-2018
• Leucocytosis is not seen in typhoid
TONY SCARIA
2010 KMC
TONY SCARIA
2010 KMC
22-04-2018
TONY SCARIA
2010 KMC
TONY SCARIA
2010 KMC
22-04-2018
TONY SCARIA
2010 KMC
• Auer rods
• Most definitive sign of myeloid differentiation
• Cluster of auer rods  faggot
TONY SCARIA
2010 KMC
22-04-2018
TONY SCARIA
2010 KMC
TONY SCARIA
2010 KMC
22-04-2018
In ALL
• Cytochemical stain  PAS +ve
• Dot like
• Block like
TONY SCARIA
2010 KMC
PAS positivity is due to glycogen deposits in
lymphoblast
TONY SCARIA
2010 KMC
22-04-2018
In M6 of AML
• Diffuse positivity by PAS
TONY SCARIA
2010 KMC
TONY SCARIA
2010 KMC
22-04-2018
Myeloblast with auer rods
TONY SCARIA
2010 KMC
TONY SCARIA
2010 KMC
22-04-2018
MPO positivity for granules in myelocytes
TONY SCARIA
2010 KMC
Non specific esterase staining for M3 M4 M5
The blasts show a strong positive reaction for non-specific
esterase, as observed by the dense orange cytoplasmic
staining. This reaction is positive in monocytic cells, and
negative in granulocytes.
TONY SCARIA
2010 KMC
22-04-2018
TONY SCARIA
2010 KMC
ALL
TONY SCARIA
2010 KMC
22-04-2018
Etiology
TONY SCARIA
2010 KMC
TONY SCARIA
2010 KMC
22-04-2018
TONY SCARIA
2010 KMC
• Tdt(terminal deoxytransferase ) a DNA polymerase present in Pre B
ALL & Pre T ALL
TONY SCARIA
2010 KMC
22-04-2018
Cytogenetics in Pre B ALL
• B cell ALL is associated with
• loss of function mutation in PAX5, E2A and EBF or
• balanced t (12;21) affecting ETV6 and RUNX1 genes (normally required for B
cell development).
• Hyperdiploidy  MC cytogenetic change
• Trisomy 4 7 & 10
• Hypoploidy
• Both hypoploidy & hyperploidy are pesent in pre B ALL
TONY SCARIA
2010 KMC
Loss of function mutation of E2A EBF PAX5
TONY SCARIA
2010 KMC
22-04-2018
TONY SCARIA
2010 KMC
TONY SCARIA
2010 KMC
22-04-2018
CD10  common ALL antigen
Pre B ALL express TdT CD 10 CD 19 CD20 PAX5
TONY SCARIA
2010 KMC
Pre T ALL
• 15 % cases
• Teenage (13 – 17 yrs of age ) in boys
• Presents as a mediastinal mass in thymus
• Early testicular involvement & early CNS manifestation d/t meningeal
spread
TONY SCARIA
2010 KMC
22-04-2018
Molecular patho genesis in Pre T ALL
• Gain of function mutation in NOTCH 1
TONY SCARIA
2010 KMC
Pre T ALL
• Teenagers
• Thymic involvement
• Testicular involvement poor prognosis
TONY SCARIA
2010 KMC
22-04-2018
Immunophenotype in pre T ALL
• TdT
• CD1
• CD2
• CD5
• CD7
TONY SCARIA
2010 KMC
Good prognosis
• Age 2-10 years
• Female sex
• white race
• Peripheral blast count <10,000
• Pre B-cell phenotype(CALLA +ve)
• L1 morphology
• Absence of mediastinal mass
• Absence of CNS involvement
• Absence of testicular involvement
• Hyperdiploidy (>50 chromosomes)
• t(12;21) or t (9:12)
• Trisomy 4,7 and 10
Bad prognosis
• Age <1 year or > 10 years
• Male sex
• Black
• Peripheral blast count >50,000
• Pre T-cell phenotype
• L2 L3 morphology
• Mediastinal mass
• CNS involvement
• Testicular involvement
• Pseudodiploidy or
• t (9;22) (Philadelphia chromosome) or t (8;14) or t
(4;11)
TONY SCARIA
2010 KMC
22-04-2018
TONY SCARIA
2010 KMC
TONY SCARIA
2010 KMC
22-04-2018
TONY SCARIA
2010 KMC
AML
TONY SCARIA
2010 KMC
22-04-2018
AML
• Adults 15 to 40 years
• Acquired oncogenic mutation
• Accumalation of immature blast cells in marrow
•  marrow failure  pancytopenia
TONY SCARIA
2010 KMC
Etiology
• Environmental
• Chemicals like benzene & alkylating agents
• Ionizing radiation
• Smoking
• Hereditary factors
• Downs syndrome
• Fanconis anemia
• AT
• Blooms syndrome
• Turner syndrome TONY SCARIA
2010 KMC
22-04-2018
TONY SCARIA
2010 KMC
Haematological conditions predisposing to
AML
• CML with blast crisis
• Myeloproliferative disorder
• Myelodysplasia
• PNH
• Aplastic anemia
TONY SCARIA
2010 KMC
22-04-2018
• Diagnosis
• Blast cell count > 20 % or more in peripheral blood or bone marrow
TONY SCARIA
2010 KMC
TONY SCARIA
2010 KMC
22-04-2018
TONY SCARIA
2010 KMC
TONY SCARIA
2010 KMC
22-04-2018
AML with recurrent genetic abnormalities
• AML t(8:21) RUNx1 fusion gene (M2)
• AML inv (16) M4E0
• Acute promyelocytic leukemia t (15:17) M3
• AML t 11q 23 MLL fusion gene  bad prognosis
• AML with normal cytogenetics & mutated NPM (nucleophosmin)
TONY SCARIA
2010 KMC
AML therapy related
• Alkylating therapy  MDS like cytogenetics changes (5q-7q-)latency
of 2-8 years
• Following of topoisomerase II inhibitors 1-3 yrs of latency
TONY SCARIA
2010 KMC
22-04-2018
AML with MDS like features
• Dysplastic changes & cytogenetics of 5q 7q 20 q
TONY SCARIA
2010 KMC
TONY SCARIA
2010 KMC
22-04-2018
TONY SCARIA
2010 KMC
AML M0
• Difficult to diagnose
• No maturation
• MPO /PAS –ve
TONY SCARIA
2010 KMC
22-04-2018
AML M3 t(15:17)
• Multiple auer rods (Faggot cells)
• Heavily granulated  strong
MPO+positivity
• Granules contain procoagulant
DIC
• Common in young female DIC
manifest as menorrhagia
TONY SCARIA
2010 KMC
AML M3
TONY SCARIA
2010 KMC
22-04-2018
AML M5  gingival hyperplasia
TONY SCARIA
2010 KMC
pancytopenia
TONY SCARIA
2010 KMC
22-04-2018
Criteria for remission in AML
• Platelet count > 1lakh
• Neutrophil >1500
• Bone marrow blast <5 % and absent auer rods
• Absence of extra medullary lesion
TONY SCARIA
2010 KMC
Chloroma
TONY SCARIA
2010 KMC
22-04-2018
Chloroma / myeloid sarcoma /granulocytic
sarcoma
• Solid tumour with myeloblast
• Extramedullary manifestation of AML
• May be hidden manifestation of AML (common in M2 / monocytic (M3orM4)
• Follow up for development of AML with bone marrow transplantation
• Mc seen in skin of orbit & periorbital tissue
TONY SCARIA
2010 KMC
TONY SCARIA
2010 KMC
22-04-2018
Arbinskov cells are monocytes in chloroma
TONY SCARIA
2010 KMC
Markers for granulocytic sarcoma
• CD 33
• CD 43
• CD 117
• Myeloperoxidase
• Lysozyme
TONY SCARIA
2010 KMC
22-04-2018
CLL
TONY SCARIA
2010 KMC
CLL
• Absolute lymphocyte count > 5000 cell/mm3
• Males are more commonly affected
• > 60 yrs
• Most common lymphoma in western world
TONY SCARIA
2010 KMC
22-04-2018
CF
Symptoms
• Fatigue (commonest
presentation)
• Infections d/t
hypogammaglobulinemia
Signs
• Lymphadenopathy
• Initially cervical  generalised
• Hepatosplenomegaly
•
TONY SCARIA
2010 KMC
• Both cell types are affected
• B cell types & T cell types (B cell >> t cell)
• Hypogammaglobulinemia +
• Auto Ab against RBC  AIHA
TONY SCARIA
2010 KMC
22-04-2018
• diagnostic criteria for CLL are:
• • Peripheral blood lymphocyte count >5000 cells/mm3with <55% cells being
atypical.
• • Bone marrow aspirate showing >30 % lymphocytes
TONY SCARIA
2010 KMC
• deletion of 13q
• commonest and has good prognosis
• Tumour suppressor genes miR15 a & miR16-
1+ on chr 13
• Deletion 11q
• trisomy 12q and
• deletion of 17p
have poor prognosis
TONY SCARIA
2010 KMC
22-04-2018
• IOC
• Flowcytometry
• Used to detect lymphocytosis & immunophenotyping
• Immunophenotyping} CD 5 CD23 CD19 cD20
TONY SCARIA
2010 KMC
Peripheral smear
• Smudge cells /parachute cells/basket
cells
• Slide artefact
• Tumour cells appear as fragile disrupted
tumour cells
formation
• Due to lack of vimentin (cytoskeletal protein
required for rigidity & integrity of cells
Smudge cells are also seen
in infections CLL a/c
leukemia
TONY SCARIA
2010 KMC
22-04-2018
Lymph node biopsy
• Large mitotic cells known as
prolymphocytes
• Divide & form diagnostic
proliferation centres
• Distortion of architecture
• Diffue effacement of LN
architecture
• Commonest
• d/t proliferation cenrtres
• Pseudofollicular pattern
• Rare TONY SCARIA
2010 KMC
Diffuse effacement of LN
TONY SCARIA
2010 KMC
22-04-2018
Basket cells in CLL
TONY SCARIA
2010 KMC
Bad prognosis
• Expression of ZAP 70
• Presence of NOTCH 1 mutation
• Deletions of 11q 17 p or trisomy 12
TONY SCARIA
2010 KMC
22-04-2018
ZAP 70 a/w poor prognosis
TONY SCARIA
2010 KMC
ZAP 70 is a/w drug resistance
TONY SCARIA
2010 KMC
22-04-2018
TONY SCARIA
2010 KMC
Transformations in CLL
• Prolymphocytic transformation
• Cb worsening of cytopenia increasing splenomegaly & large number of
prolymphocytes in circulation
• Richter syndrome
TONY SCARIA
2010 KMC
22-04-2018
Richter syndrome
• Transformation of CLL in
to DLBL
• Presents as rapidly
enlarging mass in spleen
or LN
TONY SCARIA
2010 KMC
Myelodysplastic syndrome
TONY SCARIA
2010 KMC
22-04-2018
Myelodysplastic syndrome
• Clonal stem cell disorder
• Ineffective haematopoesis
• Transformation to AML
• DD of megaloblastic anemia
TONY SCARIA
2010 KMC
• 1. Primary MDS – Develops slowly usually after 50 years of age.
• 2. Secondary or Therapy related MDS (t-MDS) –
• Usually 2 to 8 years after toxic drug or radiation exposure. The secondary
MDS gets transformed to AML most frequently and so has a poorer prognosis.
TONY SCARIA
2010 KMC
22-04-2018
TONY SCARIA
2010 KMC
TONY SCARIA
2010 KMC
22-04-2018
Erythroid lineage shows ringed sideroblast
• Iron laden
mitochondria in
perinuclear area
• Visible as blue
granules in Prussian
blue staining
• Also ssen in
• MDS
• Pb poisoning
• Sideroblastic
anemia
TONY SCARIA
2010 KMC
TONY SCARIA
2010 KMC
22-04-2018
MDS is cb DOHLE bodies in granulocytic
lineage
• Damaged RER
• Also seen in MDS
• Sepsis
• Chediak higashi syndrome
TONY SCARIA
2010 KMC
Granulocytic lineage also has pseudo pelger
huet anomaly
• Neutrophil with bilobed nuclei
• MDS
• AML with dysplastic maturation
• CML during accelerated phase
TONY SCARIA
2010 KMC
22-04-2018
Megakaryocyte lineage  pawn ball
appearance
• Either a single nuclear lobe or
multiple separate nuclei
TONY SCARIA
2010 KMC
TONY SCARIA
2010 KMC
22-04-2018
TONY SCARIA
2010 KMC
Rx
• erythropoetin
• G CSF
• Lenalidomide
• Azacytidine
• antimetabolite that inhibits DNA methylation
• BM transplantation
TONY SCARIA
2010 KMC
22-04-2018
Myeloproliferative disorders
• CML
• Polycythemia vera
• Essential thrombocythemia
• c/c idiopathic myelofibrosis
• c./c neutrophilic leukemia
• c/c eosinophilous leukemia
TONY SCARIA
2010 KMC
Common feature of MPD
• Increased proliferative drive in the marrow
• Extra medullary haematopoesis
• Spent phase transformation
• Cb marrow fibrosis & peripheral blood cytopenia
• a./c leukemia transformation
TONY SCARIA
2010 KMC
22-04-2018
• MPD may undergo transformation in to a/c leukemia
• Diagnosed by BM examination
• Blood count
• To determine proliferating cell line
• Marrow infiltration decrease in normal cells
TONY SCARIA
2010 KMC
CML
TONY SCARIA
2010 KMC
22-04-2018
Philadelphia chromosome / reciprocal
translocation / Chr t (9:22)
TONY SCARIA
2010 KMC
• LAP score will be elevated in accelerate & blast crisis
• But decreased in chronic phase
TONY SCARIA
2010 KMC
22-04-2018
P/S in CML
• Leucocytosis (>1,00,000)
• Blast count <10 %
• Consist of neutrophils (band
forms metamyelocytes &
myocytes) eosinophils &
basophils
TONY SCARIA
2010 KMC
TONY SCARIA
2010 KMC
22-04-2018
TONY SCARIA
2010 KMC
• Pseudo gaucher cells with
wrinkled cytoplasm
TONY SCARIA
2010 KMC
22-04-2018
TONY SCARIA
2010 KMC
TONY SCARIA
2010 KMC
22-04-2018
TONY SCARIA
2010 KMC
Prognostic markers
• Soklal index
• Age
• Blast (circulating)
• Cytogenetic changes
• Platelet count
• Spleen size
• Hasford index
• Age
• Blast (circulating )
• Basophils & eosinophils
• Platelet count
• Spleen size TONY SCARIA
2010 KMC
22-04-2018
TONY SCARIA
2010 KMC
Rx
• Allogenic or syngenic bone marrow transplant
• Patients in early chronic phase
• Imatinib (also used in treatment of GIST)
• DOC
• Dasatinib or IFN alpha
• Rx of accelerated or blast phase
• Hydroxyurea
• Arsenic can also be used
• Leukapheresis & splenectomyTONY SCARIA
2010 KMC
22-04-2018
TONY SCARIA
2010 KMC
Polycythemia rubra
• the most common of the chronic myeloproliferative disorders
• characterized by the increased number of erythroid, granulocytic and
megakaryocytic cells (panmyelosis)
• Mutation in JAK 2 tyrosine kinase pathway
• Can be
• Polycythemia rubra vera (primary polycythemia)
• Secondary polycythemia
TONY SCARIA
2010 KMC
22-04-2018
TONY SCARIA
2010 KMC
• Increased red cell mass
• Microcytosis with erythrocytosis
• Hb >18.5 in in males 16.5 in females
• Hyperviscosity stagnation of blood flow
• Thrombosis
• Deoxygenation  cyanosis
TONY SCARIA
2010 KMC
22-04-2018
• Extra medullary hematopoesis organomegaly
• Bone marrow  trilineage hyperplasia
• High cell turn over  hyperuricemia
• Platelet dysfunction bleeding & thrombotic events
• Basophilia  histamine release  aquagenic pruritus & peptic ulcer
TONY SCARIA
2010 KMC
• Erythropoietin is elevated in secondary polycythemia
• Decreased or normal in PCV
TONY SCARIA
2010 KMC
22-04-2018
• Causes of secondary polycythemia
• Hypoxia
• High altitude
• Lung Ca
• Smoking
• COPD
• Congenital cyanotic heart ds
• Secondary tumours producing erythropoietin
• Renal cyst
• Hypernephroma
• Hydronephrosis
• Renal A stenosis
• Cerbellar haemangioblastoma
• Hepatoma
• Pheochromocytoma TONY SCARIA
2010 KMC
Features of polycythemia
• Increased levels of vitamin B12
• Microcytosis with erythrocytosis
• Increased LAP score
• Decreased ESR
• Decreased ESR
• Polycythemia
• Afibroginemia
• CHF
• Microcytosis with erythrocytosis
• c/c hypoxia
• PCV
• Beta thalassemia
TONY SCARIA
2010 KMC
22-04-2018
• Rx
• venesection
• Anagrelide
• Decreases platelet production
• CTx
• Hydroxyurea
• Radioactive phosphorous
TONY SCARIA
2010 KMC
• Spurious / low plasma volume polycythemia
• Gaisbock syndrome
• Decrease in plasma volume  relative increase in red cell count Hb haematocrit
TONY SCARIA
2010 KMC
22-04-2018
TONY SCARIA
2010 KMC
Essential thrombocythemia
TONY SCARIA
2010 KMC
22-04-2018
Diagnostic criteria
• Sustained platelet count >4.5 lakhs/mm3
• BM biopsy
• Megakaryocyte proliferation with large & mature morphology
• Not meeting WHO critera for CML PV PMF MDS
• Demonstration of JAK2 mutation or other clonal marker
• No evidence of reactive thrombocytosis
TONY SCARIA
2010 KMC
TONY SCARIA
2010 KMC
22-04-2018
Rx
• Aspirin low dose 60mg/day
• Busulfan /hydroxyurea
• Interferon alpha
• Radioactive phosphorous
• Anagrelide
TONY SCARIA
2010 KMC
TONY SCARIA
2010 KMC
22-04-2018
Primary myelofibrosis
TONY SCARIA
2010 KMC
Tear drop cells + leucoerythroblastic picture
TONY SCARIA
2010 KMC
22-04-2018
• BM biopsy for
marrow fibrosis
• Initially hypercellular
• Then becomes
hypocellular
• Abnormal
megakaryocytes with
unusual nuclear
shapes
• Dilated marrow
sinusoids
TONY SCARIA
2010 KMC
Silver staining for reticulin
TONY SCARIA
2010 KMC
22-04-2018
Staining with masons trichrome S
TONY SCARIA
2010 KMC
TONY SCARIA
2010 KMC
22-04-2018
Myeloproliferative /
myelodysplastic neoplasm
TONY SCARIA
2010 KMC
• Clonal myeloid disorders
• Both dysplastic & proliferative features not classified in MDS /MPN
• Chronic myelomonocytic leukemia (CMML)
• Juvenile myelomonocytic leukemia
• Atypical CML
TONY SCARIA
2010 KMC
22-04-2018
CMML
• Most common MDS MPN
• Absence of Philadelphia chromosome
TONY SCARIA
2010 KMC
TONY SCARIA
2010 KMC
22-04-2018
JMML
• children <2yrs
• 2% child hood leukemia
• Children with NF1 are at increased risk for development of JMML
TONY SCARIA
2010 KMC
Major criteria (all the three)
• Absence of Ph chromosome
• Peripheral monocytes greater
than 1*10^9 /L
• Less than 20 % blast
Minor criteria
• HbF raised
• Immature granulocytes in
peripheral blood
• WBC count > 1*10^9 /L
• Clonal chromosomal
abnormality (monosomy 7)
• GM CSF hypersensitivity of
myeloid progenitors in vitroTONY SCARIA
2010 KMC
22-04-2018
Atypical CML
TONY SCARIA
2010 KMC
• Rx
• Very aggressive
• But chemosensitive
TONY SCARIA
2010 KMC
22-04-2018
Peripheral B cell neoplasm
TONY SCARIA
2010 KMC
Basics
TONY SCARIA
2010 KMC
22-04-2018
TONY SCARIA
2010 KMC
Mantle cell lymphoma
• B cell lymphoma
• Arises from naive B cells
• Males of 50 – 60 yrs
• Presents as painless lymphadenopathy
TONY SCARIA
2010 KMC
22-04-2018
T(11:14) is seen in mantle zone lymphoma
Bcl 1 = cyclin D!
TONY SCARIA
2010 KMC
• Express cyclin D1 (= Bcl1) &
surface Ig
• CD 5+ CD23-ve (CD5 +ve CD
23 +ve in CLL)
• Charcteristic pattern of
spread is also known as
LYMPHOMATOID POLYPOSIS
LYMPHOMATOID POLYPOSIS
TONY SCARIA
2010 KMC
22-04-2018
Diffuse large b cell lymphoma
• Most common NHL
• Most malignant  WORST prognosis
• Affects older individual Medial age of 60 years
• mature B cell tumour
TONY SCARIA
2010 KMC
Immunophenotyping of DLBL
• CD 19 CD20
• Variable expression of germinal center markers such as Bcl-6 or CD10
• Surface Ig+
TONY SCARIA
2010 KMC
22-04-2018
Cytogenetics of DLBL
• Translocations involving Bcl-6
• Translocation t(14:18)
overexpression of Bcl-2  decreased
apoptosis
• MYC tranlocatins
TONY SCARIA
2010 KMC
Special types of DLBL
• Immunodeficiency associated large B cell lymphoma
• In severe T cell immunodeficiency like HIV & bone marrow transplantation
• Neoplastic cells are latently infected with EBV
• Restoration of T cell immunity  regression of tumour
• Primary effusion lymphoma
• Seen in elderly
• As malignant pleural or ascetic effusion
• Tumour cells  anaplastic  lack T or B cell markers
• Tumour cells are infected with human Kaposi sarcoma herpes virus
TONY SCARIA
2010 KMC
22-04-2018
Follicular lymphoma
• B cell lymphoma arising from germinal
centre
• LN biopsy
• Centrocytes
• Small cells with cleaved nuclear contours &
scanty cytoplasm (buttock cells )
• Centroblast
• Large cells with open nuclear chromatin
several nucleoli modest amount of cytoplasm
TONY SCARIA
2010 KMC
TONY SCARIA
2010 KMC
22-04-2018
• BM biopsy  paratrabecular
lymphoid aggregates in follicular
lymphoma
TONY SCARIA
2010 KMC
Translocation of 14 : 18  follicular
lymphoma
Over expression of Bcl2
30-50 % transform in to DLBCL
TONY SCARIA
2010 KMC
22-04-2018
Cytogenetics of follicular lymphoma
• CD19 CD20
• Arising from germinal centre Bcl -6 & CD10
TONY SCARIA
2010 KMC
Marginal zone lymphoma  MALToma
• Mucosa associated lymphoid issue  MALToma
• Resembles normal marginal zone B cell
• Most common site is stomach
• 3 characteristic features
• a/w c/c inflammatory conditions
• like psojgrens syndrome
• Hashimotos thyroiditis
• Stomach H pylori infection
• Remain localized for long periods
• Regress on removal of inciting stimulus
• Upregulation of Bcl10 or MALT1
TONY SCARIA
2010 KMC
22-04-2018
TONY SCARIA
2010 KMC
Cytogenetics a/w MALToma
• t(11:18)resistant to Ctx
• T(14:18)
• T(1:14)
TONY SCARIA
2010 KMC
22-04-2018
Burkitts lymphoma
• Peripheral B cell neoplasm
• ALL L3
• most common cause of tumour lysis syndrome
TONY SCARIA
2010 KMC
T(8:14)in burkitts lymphoma
TONY SCARIA
2010 KMC
22-04-2018
TONY SCARIA
2010 KMC
C-myc gene on chromosome 8
TONY SCARIA
2010 KMC
22-04-2018
3 categories of burkitts lymphoma
• African endemic
• Sporadic (non endemic)
• HIV associated aggressive
TONY SCARIA
2010 KMC
African endemic
• Most commonly affects face
/mandible
• Children / young adults
• All cases will be latently infected with
EBV
TONY SCARIA
2010 KMC
22-04-2018
Sporadic (nonendemic ) BL
• Seen in children /young adults
• Presents as Illeocaecal / peritoneal
mass
• 15 – 20 % latently infected with EBV
TONY SCARIA
2010 KMC
HIV associated aggressive lymphomas
• 25 % of the patients are latently infected by EBV
TONY SCARIA
2010 KMC
22-04-2018
Starry sky pattern due to apoptotic tumour
cell laden foamy macrophages
TONY SCARIA
2010 KMC
TONY SCARIA
2010 KMC
22-04-2018
• Immunophenotyping reveals the cells expressing
• bcl-6 protein,
• surface Ig, CD19, CD20 and
• CD10 (CALLA)
TONY SCARIA
2010 KMC
TONY SCARIA
2010 KMC
22-04-2018
Immunostaining of burkitts lymphoma
• Ki 67
• MIB1
• PCNA
• AgNOR
TONY SCARIA
2010 KMC
Hairy cell leukemia
TONY SCARIA
2010 KMC
22-04-2018
Hairy cell leukemia
• Middle aged
• Male (M:F=6:1)
• Indolent course
• Peripheral B cell neoplasm
TONY SCARIA
2010 KMC
• Hairy cells are best seen by phase contrast microscopy
TONY SCARIA
2010 KMC
22-04-2018
Triad of HCL
• Pancytopenia
• Massive splenomegaly (no lymph node enlargement)
• Most common presentation
• Vasculitis like syndrome (erythema nodosum)
TONY SCARIA
2010 KMC
TRAP positivity
TONY SCARIA
2010 KMC
22-04-2018
TONY SCARIA
2010 KMC
Fried egg appearance of hairy cell in bone
marrow /honey comb appearance
TONY SCARIA
2010 KMC
22-04-2018
Immunophenotyping
• Pan B markers
• CD 19 CD 20 surface Ig
• Monocyte specific
• CD11c
• CD25
• Characteristically expression of hairy cell leukemia
• CD103
• T cell specific
• Annexin A1
• Best & specific
TONY SCARIA
2010 KMC
TONY SCARIA
2010 KMC
22-04-2018
• Rx
• Chemosensitive
• Cladiribine & deoxycoformycin
• Splenectomy for severe pancytopenia
• Good prognosis
TONY SCARIA
2010 KMC
Peripheral T cell neoplasm
TONY SCARIA
2010 KMC
22-04-2018
Mycosis fungoides
• Tumour of CD4 + helper T cells
• Epidermotropism
• d/t cutaneous localizaition of tumour cells
• Chemokine receptors CCR4 & CCR10
TONY SCARIA
2010 KMC
Pautriers microabscess
TONY SCARIA
2010 KMC
22-04-2018
TONY SCARIA
2010 KMC
Cerebriform nuclei
TONY SCARIA
2010 KMC
22-04-2018
TONY SCARIA
2010 KMC
Mycosis fungoides (cutaneous T cell
lymphoma)
• NHL presenting with skin infiltration
• MC primary cutaneous lymphoma of T cell origin
• In middle aged males and blacks
• C/F
• Pruritic localised erythematous plaques on trunk > 5 cm
TONY SCARIA 2010 KMC
22-04-2018
Pautrier microabscess is characteristic of MF.
pleomorhic lymphocytes as clusters in epidermis
TONY SCARIA 2010 KMC
Sezary syndrome
• Advanced MF with lypmpadenpathy and visceral spread
• Generalised exfoliative erythroderma
• Circulating atypical lymphocytes(sezrry cells)
• Detected by T – cell rearrangement test
TONY SCARIA 2010 KMC
22-04-2018
• Mycosis fungoides is an indolent cutaneous T-cell lymphoma (indolent
course) but is inevitably fatal (not easily amenable to treatment), except for
patients in stage I.
• Localised d/s
• Topical N2 mustard, corticosteroids,bexarotene PUVA
• Advanced
• PUVA+ oral retinoids
• Electron beam therapy
• denileukin
• Romidepsin
• Vorinostat
• Alemtuzumab(anti – CD 52 Ab)
• histone deacetylase inhibitors
TONY SCARIA 2010 KMC
• It has 3 phases
• Inflammatory premycotic phase
• Plaque phase
• Tumor phase
TONY SCARIA 2010 KMC
22-04-2018
TONY SCARIA 2010 KMC
sezary syndrome
• Leukemic phase of
disease
• Sezry cells in peripheral
smear
• Cerebriform nuclei
• Generalized exfoliative
erythroderma
TONY SCARIA
2010 KMC
22-04-2018
Large granular lymphocytic leukemia
• Occuring mainly in adults
• Neutropenia anemia
• Pure red cell aplasia  anemia
• a/w
• Rheumatological disorder
• feltys syndrome
• RA
• Splenomegaly
• Neutropenia
TONY SCARIA
2010 KMC
Adult T cell leukemia
• Neoplasm of CD4 + T cells
• Endemicity
• CF
• Lymhadenopathy
• HSM
• Skin lesions
TONY SCARIA
2010 KMC
22-04-2018
HTLV 1 tax gene
TONY SCARIA
2010 KMC
TONY SCARIA
2010 KMC
22-04-2018
• Clover leaf cells / flower cells
TONY SCARIA
2010 KMC
Anaplastic large cell lymphoma
TONY SCARIA
2010 KMC
22-04-2018
TONY SCARIA
2010 KMC
TONY SCARIA
2010 KMC
22-04-2018
NK cells
TONY SCARIA
2010 KMC
NK cell granuloma
• Extranodal Midline
• Destructive nasopharyngeal mass
• Invade vessels  ischemic necrosis
• EBV associated
• CD 16 & 56
• CD 3 –ve
TONY SCARIA
2010 KMC
22-04-2018
Miscellaneous
TONY SCARIA
2010 KMC
Post transplantation lympho proliferative ds
• Diverse group of abnormal lymphoid growth
• Consisting of both hyperplasia & neoplasia
• Majority are Bcell origin
• Rarely t cell or NK cell
TONY SCARIA
2010 KMC
22-04-2018
Hodgkins lymphoma
TONY SCARIA
2010 KMC
TONY SCARIA
2010 KMC
22-04-2018
TONY SCARIA
2010 KMC
• Arises single node and spreads by contiguous spread
• Reed sternberg cells
• derived from the germinal center B cell
• induces the accumulation of reactive lymphocytes, macrophages and
granulocytes
• Neoplastic giant cell
• Owl eye appearance
• Also seen in IMN
• NHL (immunoblastic NHL)
• Carcinoma & sarcoma
TONY SCARIA
2010 KMC
22-04-2018
TONY SCARIA
2010 KMC
TONY SCARIA
2010 KMC
22-04-2018
• “owl-eye” appearance
• due to the presence of symmetric
(mirror image) bilobed nucleus
with prominent nucleoli
surrounded by clear space
• PAX 5 is best marker for reed
Sternberg cell
TONY SCARIA
2010 KMC
TONY SCARIA
2010 KMC
22-04-2018
• Classical reed Sternberg cells
• Express PAX5 CD15 & CD30
• Lymphohistiocytic variant
• Will express germinal center B cells (CD20 & Bcl 6)
TONY SCARIA
2010 KMC
TONY SCARIA
2010 KMC
22-04-2018
TONY SCARIA
2010 KMC
TONY SCARIA
2010 KMC
22-04-2018
NODULAR SCLEROSIS TYPE
• MOST COMMON IN WORLD
• abundant collagen +
• Mediatinal involvement  common
TONY SCARIA
2010 KMC
TONY SCARIA
2010 KMC
22-04-2018
Mixed cellularity
• Most common in developing countries
• Biphasic incidence
Young age >55 years
TONY SCARIA
2010 KMC
TONY SCARIA
2010 KMC
22-04-2018
Lymphocyte rich histiocytes
TONY SCARIA
2010 KMC
Lymphocyte
depleted
• Lymphocyte depleted
• Mummified RS cells
TONY SCARIA
2010 KMC
22-04-2018
Lymphocyte predominant
• Popcorn cell
• L&H variant
• fluffy, lobulated nucleus having fine chromatin and small nucleoli.
TONY SCARIA
2010 KMC
TONY SCARIA
2010 KMC
22-04-2018
TONY SCARIA
2010 KMC
CF of hodgkins lymphoma
• Alcohol increases symptoms
• Pel ebstein fever
• Fever which cyclically increase in one
or two weeks
• Painless rubbery enlargement of LN
• Paraneoplastic syndrome in HL
• Secondary amyloidosis (AA)
• Alchol induced pain in LN
TONY SCARIA
2010 KMC
22-04-2018
Adverse prognostic factors
• Age > 45 yrs
• Male
• Hb <10.5gm/dL
• Leucocyte count >15000
• Lymphocytopenia
• Absolute lymphocyte count <600/ul
• Lymphocyte <8 %
• Serum albumin <4gm/dL
• Stage IV TONY SCARIA
2010 KMC
TONY SCARIA
2010 KMC
22-04-2018
Best prognosis
• Lymphocyte predominant >> nodular sclerosis
TONY SCARIA
2010 KMC
Bad prognosis
• Mediastinal involvement
• Lymphocyte depletion type
• Systemic symptoms
TONY SCARIA
2010 KMC
22-04-2018
Ann arbor staging
TONY SCARIA
2010 KMC
Rx
• ABVD is more effective than MOPP
TONY SCARIA
2010 KMC
22-04-2018
IMN
• Atypical lymphocytes in peripheral smear
• DOWNEY CELLS
• Atypical lymphocytes  activated CD8 –T (cytotoxic) cells
• Ballerina skirt appearance
TONY SCARIA
2010 KMC
PLASMA CELL NEOPLASMS
TONY SCARIA
2010 KMC
22-04-2018
Plasma cell neoplasm
• Neoplasm of terminally differentiated B cells
TONY SCARIA
2010 KMC
TONY SCARIA
2010 KMC
22-04-2018
Multiple myeloma
• Clonal plasma cells >10 % on BM biopsy
• Or in any quantity in biopsy from other tissues  plamcocytoma
• Monoclonal protein in either serum or urine
• Except in cases of true non secretory myeloma
• Evidence of end organ damage
• CRAB
• Calcium elevation >11.5 Hypercalcemia
• Renal insufficiency (s creatinine >2mg/dl
• Anemia (haemoglobin <10gm/dl)
• Bone lesions (lytic lesion/osteoporosis with compression#)
TONY SCARIA
2010 KMC
Plasma cell leukemia
TONY SCARIA
2010 KMC
22-04-2018
• Multiple myeloma
• Age group 65 and 70 yrs
TONY SCARIA
2010 KMC
TONY SCARIA
2010 KMC
22-04-2018
Radiographically
• Punched out lesions will be
seen
• Vertebrae is most commonly
involved
• Vertebra>>ribs>>skull>.pelvis
>>femur >> clavicle
TONY SCARIA
2010 KMC
Hypercalcemia
• Hypercalcemia metasatic calcification
TONY SCARIA
2010 KMC
22-04-2018
TONY SCARIA
2010 KMC
TONY SCARIA
2010 KMC
22-04-2018
Immunity
• Hypogammaglobulinemia  decreased humoral immunity
• Cellular immunity is normal
TONY SCARIA
2010 KMC
Hyperviscosity syndrome
TONY SCARIA
2010 KMC
22-04-2018
TONY SCARIA
2010 KMC
Old diagnostic criteria
TONY SCARIA
2010 KMC
22-04-2018
• Definitive diagnosis is with bone marrow examination
TONY SCARIA
2010 KMC
Marked rouleaux formation d/t M proteins
TONY SCARIA
2010 KMC
22-04-2018
Plasma cells
TONY SCARIA
2010 KMC
TONY SCARIA
2010 KMC
22-04-2018
FlAme cells (IgA myeloma)
TONY SCARIA
2010 KMC
Russel bodies are inclusions in Endoplasmic
reticulum
TONY SCARIA
2010 KMC
22-04-2018
Mott cells  multiple russel bodies
TONY SCARIA
2010 KMC
TONY SCARIA
2010 KMC
22-04-2018
Complications of multiple myeloma
• Systemic amyloidosis
• Hyperviscosity syndrome
• Renal failure
• Hypercalcemia
• Spinal cord compression
TONY SCARIA
2010 KMC
TONY SCARIA
2010 KMC
22-04-2018
TONY SCARIA
2010 KMC
TONY SCARIA
2010 KMC
22-04-2018
Poor prognostic factors for multiple myeloma
• Serum β2 macroglobulin >6mg/dl
• Best prognostic marker
• CRP > 6mg/dl
• Presence of plasmablastic morphology
• Bone marrow biopsy  diffuse pattern & prominent angiogenesis
• Serum LDH  raised
• Serum creatinine > 2mg/dl
• Plasma cell labelling index > 3 %
• Cytogenetics
• Deletion of 13q 11p
• Monosomy 13
• Hypodiploidy TONY SCARIA
2010 KMC
In multiple myeloma
• Anion gap is less than normal
• Bcz M protein is cationic  leads to retention of chloride
TONY SCARIA
2010 KMC
22-04-2018
Rx
• Thalidomide
• Leflunomide
• Bortezomib  proteasome inhibitor
TONY SCARIA
2010 KMC
• Plasma cell leukemia
• Plasma cells more than 20 % of cells
• Absolute plasma cell count of more than 2000cells /mm3
TONY SCARIA
2010 KMC
22-04-2018
• Nonsecretory myeloma
• No M band in serum or urine
• All other symptoms of MM+
• Rare
TONY SCARIA
2010 KMC
Waldenstroms macroglobulinemia
• B cell neoplasm
• Affecting 60 -70 yrs
• No bone destructin
TONY SCARIA
2010 KMC
22-04-2018
TONY SCARIA
2010 KMC
TONY SCARIA
2010 KMC
22-04-2018
MGUS
• presence of M spike without associated disease of the B cells. MGUS is the
• commonest cause of monoclonal gammopathy. Around 1% of the patients
with MGUS progress to develop multiple myeloma per year. It is usually a
diagnosis of exclusion.
• Patients of MGUS have less than 3 g/dL of monoclonal protein in the serum
and no Bence Jones proteinuria
• Normal calcium
• Rx
• Symptomatic
• Follow up TONY SCARIA
2010 KMC
Heavy chain disease
TONY SCARIA
2010 KMC
22-04-2018
Langerhancell histiocytosis
TONY SCARIA
2010 KMC
TONY SCARIA
2010 KMC
22-04-2018
• Cleaved nucleus
• Several granules in cytoplasm 
BIRBECK granules
TONY SCARIA
2010 KMC
TONY SCARIA
2010 KMC
22-04-2018
Clinicopathological entities of LCH
• Letterer – siwe disease
• Multifocal multisystem
• Aggressive systemic disorder occurring before 2 yrs of age
• Presents like seborrheic dermatitis
• Bone destruction involving all bones of body
• Eosinophilic granuloma
• Unifocal & multifocal unisystem
• Mc presentation is calvarial skull defect
• Hand schuller Christian syndrome
• Calvarial bone defects
• Diabetes insipidus
• Exophthalmos
• Pulmonary lan
TONY SCARIA
2010 KMC
TONY SCARIA
2010 KMC
22-04-2018
TONY SCARIA
2010 KMC
Exophthalmos
TONY SCARIA
2010 KMC
22-04-2018
Flow cytometry
TONY SCARIA
2010 KMC
TONY SCARIA
2010 KMC
22-04-2018
TONY SCARIA
2010 KMC
TONY SCARIA
2010 KMC
22-04-2018
Forward scatter
• To determine cell size
TONY SCARIA
2010 KMC
Side scatter
• For density of cell (granularity
vacuoles membrane size )
• Granulocytes & monocytes have
more granularity  hence more
scattering
TONY SCARIA
2010 KMC
22-04-2018
• Pan-B cell markers are CD19, 20 and 21. CD21 is also acts as the
receptor of EBV.
TONY SCARIA
2010 KMC
Clinical uses of flow cytometry
• Diagnosis of PNH
• Reticulocyte enumeration
• Leukemia & lymphoma phenotyping
• transplant rejection
• Lymphocytosis
TONY SCARIA
2010 KMC
22-04-2018
TONY SCARIA
2010 KMC
TONY SCARIA
2010 KMC
22-04-2018
Massive splenomegaly
• CML
• Idioathic myelofibrosis
• Gauchers ds
• Hairy cell leukemia
• Tropical splenomegaly
• Malaria
• Hypersplenism
TONY SCARIA
2010 KMC
TONY SCARIA
2010 KMC
22-04-2018
Digeorge syndrome  T cell deficiency
TONY SCARIA
2010 KMC
Microdeletion @ 22q11.2  digeorge
syndrome
TONY SCARIA
2010 KMC
22-04-2018
TONY SCARIA
2010 KMC
TONY SCARIA
2010 KMC
22-04-2018
TONY SCARIA
2010 KMC
TONY SCARIA
2010 KMC
22-04-2018
Alder reily anomaly
• In mucopolysacharidose
• AR  inherited MPS
• Mucopysaccharidoses
TONY SCARIA
2010 KMC
TONY SCARIA
2010 KMC
22-04-2018
May hegglin anomaly
• AD
• Associated with macrothrombocytes
• Giant platelets with thrombocytopenia
TONY SCARIA
2010 KMC
TONY SCARIA
2010 KMC
22-04-2018
TONY SCARIA
2010 KMC
Kikuchis disease
• Necrotising histiocytic lymphadenitis
TONY SCARIA
2010 KMC
22-04-2018
Kimuras disease
• Eosinophilic lymphadenitis
TONY SCARIA
2010 KMC
• The LAP score is usually decreased in chronic myelogenous leukemia
and paroxysmal nocturnal hemoglobinuria, while it is increased in
leukemoid reaction and polycythemia vera.
TONY SCARIA
2010 KMC

More Related Content

What's hot

Lymphopoiesis
LymphopoiesisLymphopoiesis
Lymphopoiesis
Medina College
 
Lab Diagnosis of Chronic lymphoproliferative disorders (CLPD); Flowcytometric...
Lab Diagnosis of Chronic lymphoproliferative disorders (CLPD);Flowcytometric...Lab Diagnosis of Chronic lymphoproliferative disorders (CLPD);Flowcytometric...
Lab Diagnosis of Chronic lymphoproliferative disorders (CLPD); Flowcytometric...
Dr Siddartha
 
Acute myeloid leukemia
Acute myeloid leukemiaAcute myeloid leukemia
Acute myeloid leukemia
Monika Nema
 
The 5th edition of the World Health Organization Classification of Haematolym...
The 5th edition of the World Health Organization Classification of Haematolym...The 5th edition of the World Health Organization Classification of Haematolym...
The 5th edition of the World Health Organization Classification of Haematolym...
Dr Seena Tresa Samuel
 
Leukemia
LeukemiaLeukemia
Small round cell tumors
Small round cell tumorsSmall round cell tumors
Small round cell tumors
Dr Niharika Singh
 
Bethesda system for reporting thyroid cytology
Bethesda system for reporting thyroid cytologyBethesda system for reporting thyroid cytology
Bethesda system for reporting thyroid cytology
ariva zhagan
 
Non Hodgkin Lymphoma, cytology.
Non Hodgkin Lymphoma, cytology.Non Hodgkin Lymphoma, cytology.
Non Hodgkin Lymphoma, cytology.
DrPradeep Shekhawat
 
Fungi in tissue sections
Fungi in tissue sectionsFungi in tissue sections
Fungi in tissue sections
Drsapna Harsha
 
Myelodysplastic syndrome
Myelodysplastic syndromeMyelodysplastic syndrome
Myelodysplastic syndrome
Dr. Pritika Nehra
 
Lymphoma spillover.pptx
Lymphoma spillover.pptxLymphoma spillover.pptx
Lymphoma spillover.pptx
Tamil Mahizhenthi
 
Cytologic assessment of bronchopulmonary lesions
Cytologic assessment of bronchopulmonary lesionsCytologic assessment of bronchopulmonary lesions
Cytologic assessment of bronchopulmonary lesions
Aseem Jain
 
Myelodysplastic syndrome according to WHO 2016
Myelodysplastic syndrome according to WHO 2016Myelodysplastic syndrome according to WHO 2016
Myelodysplastic syndrome according to WHO 2016
Madhuri Reddy
 
Yokohama system cytology
Yokohama system cytologyYokohama system cytology
Yokohama system cytology
BPS GMC (W) KHANPUR KALAN SONEPAT
 
Perl's stain
Perl's stainPerl's stain
Perl's stain
manoj pant
 
Acute leukemia
Acute leukemia Acute leukemia
Acute leukemia
anil kumar g
 
Imprint cytology
Imprint cytology Imprint cytology
Imprint cytology
Sindhuja Yella
 
Immunohistochemistry
Immunohistochemistry Immunohistochemistry
Immunohistochemistry
Appy Akshay Agarwal
 
Plasma cell dyscrasias
Plasma cell dyscrasias Plasma cell dyscrasias
Plasma cell dyscrasias
Prince Lokwani
 
CYTOLOGY OF CSF
CYTOLOGY OF CSFCYTOLOGY OF CSF
CYTOLOGY OF CSFMusa Khan
 

What's hot (20)

Lymphopoiesis
LymphopoiesisLymphopoiesis
Lymphopoiesis
 
Lab Diagnosis of Chronic lymphoproliferative disorders (CLPD); Flowcytometric...
Lab Diagnosis of Chronic lymphoproliferative disorders (CLPD);Flowcytometric...Lab Diagnosis of Chronic lymphoproliferative disorders (CLPD);Flowcytometric...
Lab Diagnosis of Chronic lymphoproliferative disorders (CLPD); Flowcytometric...
 
Acute myeloid leukemia
Acute myeloid leukemiaAcute myeloid leukemia
Acute myeloid leukemia
 
The 5th edition of the World Health Organization Classification of Haematolym...
The 5th edition of the World Health Organization Classification of Haematolym...The 5th edition of the World Health Organization Classification of Haematolym...
The 5th edition of the World Health Organization Classification of Haematolym...
 
Leukemia
LeukemiaLeukemia
Leukemia
 
Small round cell tumors
Small round cell tumorsSmall round cell tumors
Small round cell tumors
 
Bethesda system for reporting thyroid cytology
Bethesda system for reporting thyroid cytologyBethesda system for reporting thyroid cytology
Bethesda system for reporting thyroid cytology
 
Non Hodgkin Lymphoma, cytology.
Non Hodgkin Lymphoma, cytology.Non Hodgkin Lymphoma, cytology.
Non Hodgkin Lymphoma, cytology.
 
Fungi in tissue sections
Fungi in tissue sectionsFungi in tissue sections
Fungi in tissue sections
 
Myelodysplastic syndrome
Myelodysplastic syndromeMyelodysplastic syndrome
Myelodysplastic syndrome
 
Lymphoma spillover.pptx
Lymphoma spillover.pptxLymphoma spillover.pptx
Lymphoma spillover.pptx
 
Cytologic assessment of bronchopulmonary lesions
Cytologic assessment of bronchopulmonary lesionsCytologic assessment of bronchopulmonary lesions
Cytologic assessment of bronchopulmonary lesions
 
Myelodysplastic syndrome according to WHO 2016
Myelodysplastic syndrome according to WHO 2016Myelodysplastic syndrome according to WHO 2016
Myelodysplastic syndrome according to WHO 2016
 
Yokohama system cytology
Yokohama system cytologyYokohama system cytology
Yokohama system cytology
 
Perl's stain
Perl's stainPerl's stain
Perl's stain
 
Acute leukemia
Acute leukemia Acute leukemia
Acute leukemia
 
Imprint cytology
Imprint cytology Imprint cytology
Imprint cytology
 
Immunohistochemistry
Immunohistochemistry Immunohistochemistry
Immunohistochemistry
 
Plasma cell dyscrasias
Plasma cell dyscrasias Plasma cell dyscrasias
Plasma cell dyscrasias
 
CYTOLOGY OF CSF
CYTOLOGY OF CSFCYTOLOGY OF CSF
CYTOLOGY OF CSF
 

Similar to Leukemia and lymphoma PATHOLOGY REVISION NOTES

Retinoblastoma revision notes
Retinoblastoma revision notes Retinoblastoma revision notes
Retinoblastoma revision notes
TONY SCARIA
 
CHILDHOOD MALIGNANCIES REVISION NOTES
CHILDHOOD MALIGNANCIES REVISION NOTESCHILDHOOD MALIGNANCIES REVISION NOTES
CHILDHOOD MALIGNANCIES REVISION NOTES
TONY SCARIA
 
Hematology revision notes pathology
Hematology revision notes pathology Hematology revision notes pathology
Hematology revision notes pathology
TONY SCARIA
 
Glomerular disorders OF KIDNEY REVISION NOTES
Glomerular disorders OF KIDNEY REVISION NOTESGlomerular disorders OF KIDNEY REVISION NOTES
Glomerular disorders OF KIDNEY REVISION NOTES
TONY SCARIA
 
Rheumatology revison notes
Rheumatology revison notes Rheumatology revison notes
Rheumatology revison notes
TONY SCARIA
 
Leukemia
LeukemiaLeukemia
Leukemia
Badheeb
 
Acute myeloid leukemia
Acute myeloid leukemiaAcute myeloid leukemia
Acute myeloid leukemia
Pradip Katwal
 
Acute myeloid leukemia
Acute myeloid leukemiaAcute myeloid leukemia
Acute myeloid leukemia
ajayyadav753
 
LEUKEMIC DISEASES AND THE EYE.pptx. This talks about the ocular manifestation...
LEUKEMIC DISEASES AND THE EYE.pptx. This talks about the ocular manifestation...LEUKEMIC DISEASES AND THE EYE.pptx. This talks about the ocular manifestation...
LEUKEMIC DISEASES AND THE EYE.pptx. This talks about the ocular manifestation...
BARNABASMUGABI
 
Adult Myelodysplastic/myeloproliferative neoplasms
Adult Myelodysplastic/myeloproliferative neoplasmsAdult Myelodysplastic/myeloproliferative neoplasms
Adult Myelodysplastic/myeloproliferative neoplasms
Nilay Nishith
 
Acute Myeloid Leukemia
Acute Myeloid LeukemiaAcute Myeloid Leukemia
9. Chronic Myeloid Leukaemia.ppt
9. Chronic Myeloid Leukaemia.ppt9. Chronic Myeloid Leukaemia.ppt
9. Chronic Myeloid Leukaemia.ppt
AnayaKhan992603
 
Chronic myeloid Leukemia
Chronic myeloid LeukemiaChronic myeloid Leukemia
Chronic myeloid Leukemia
MLT LECTURES BY TANVEER TARA
 
Approach to Pancytopenia with cases.pptx
Approach to Pancytopenia with cases.pptxApproach to Pancytopenia with cases.pptx
Approach to Pancytopenia with cases.pptx
YogeetaTanty1
 
Recent advances in leukemia (2019)
Recent advances in leukemia (2019)Recent advances in leukemia (2019)
Recent advances in leukemia (2019)
MIMSR Medical college,Latur
 
Ca kidney [edmond]
Ca kidney [edmond]Ca kidney [edmond]
Ca kidney [edmond]
Edmond Wong
 
Chronic Lymphocytic Leukemia ,laboratory findings,
Chronic Lymphocytic Leukemia ,laboratory findings,Chronic Lymphocytic Leukemia ,laboratory findings,
Chronic Lymphocytic Leukemia ,laboratory findings,
DeepshikhaSinghmar
 
DIAGNOSIS AND MANAGEMENT OF MYELOPROLIFERATIVE NEOPLASMS
DIAGNOSIS AND MANAGEMENT OF MYELOPROLIFERATIVE NEOPLASMSDIAGNOSIS AND MANAGEMENT OF MYELOPROLIFERATIVE NEOPLASMS
DIAGNOSIS AND MANAGEMENT OF MYELOPROLIFERATIVE NEOPLASMSNatalia Curto García
 
An introduction to haematological malignancies
An introduction to haematological malignanciesAn introduction to haematological malignancies
An introduction to haematological malignanciesmeducationdotnet
 
ACUTE LYMPHOBLASTIC LEUKAEMIA.pptx
ACUTE LYMPHOBLASTIC LEUKAEMIA.pptxACUTE LYMPHOBLASTIC LEUKAEMIA.pptx
ACUTE LYMPHOBLASTIC LEUKAEMIA.pptx
MaRy767337
 

Similar to Leukemia and lymphoma PATHOLOGY REVISION NOTES (20)

Retinoblastoma revision notes
Retinoblastoma revision notes Retinoblastoma revision notes
Retinoblastoma revision notes
 
CHILDHOOD MALIGNANCIES REVISION NOTES
CHILDHOOD MALIGNANCIES REVISION NOTESCHILDHOOD MALIGNANCIES REVISION NOTES
CHILDHOOD MALIGNANCIES REVISION NOTES
 
Hematology revision notes pathology
Hematology revision notes pathology Hematology revision notes pathology
Hematology revision notes pathology
 
Glomerular disorders OF KIDNEY REVISION NOTES
Glomerular disorders OF KIDNEY REVISION NOTESGlomerular disorders OF KIDNEY REVISION NOTES
Glomerular disorders OF KIDNEY REVISION NOTES
 
Rheumatology revison notes
Rheumatology revison notes Rheumatology revison notes
Rheumatology revison notes
 
Leukemia
LeukemiaLeukemia
Leukemia
 
Acute myeloid leukemia
Acute myeloid leukemiaAcute myeloid leukemia
Acute myeloid leukemia
 
Acute myeloid leukemia
Acute myeloid leukemiaAcute myeloid leukemia
Acute myeloid leukemia
 
LEUKEMIC DISEASES AND THE EYE.pptx. This talks about the ocular manifestation...
LEUKEMIC DISEASES AND THE EYE.pptx. This talks about the ocular manifestation...LEUKEMIC DISEASES AND THE EYE.pptx. This talks about the ocular manifestation...
LEUKEMIC DISEASES AND THE EYE.pptx. This talks about the ocular manifestation...
 
Adult Myelodysplastic/myeloproliferative neoplasms
Adult Myelodysplastic/myeloproliferative neoplasmsAdult Myelodysplastic/myeloproliferative neoplasms
Adult Myelodysplastic/myeloproliferative neoplasms
 
Acute Myeloid Leukemia
Acute Myeloid LeukemiaAcute Myeloid Leukemia
Acute Myeloid Leukemia
 
9. Chronic Myeloid Leukaemia.ppt
9. Chronic Myeloid Leukaemia.ppt9. Chronic Myeloid Leukaemia.ppt
9. Chronic Myeloid Leukaemia.ppt
 
Chronic myeloid Leukemia
Chronic myeloid LeukemiaChronic myeloid Leukemia
Chronic myeloid Leukemia
 
Approach to Pancytopenia with cases.pptx
Approach to Pancytopenia with cases.pptxApproach to Pancytopenia with cases.pptx
Approach to Pancytopenia with cases.pptx
 
Recent advances in leukemia (2019)
Recent advances in leukemia (2019)Recent advances in leukemia (2019)
Recent advances in leukemia (2019)
 
Ca kidney [edmond]
Ca kidney [edmond]Ca kidney [edmond]
Ca kidney [edmond]
 
Chronic Lymphocytic Leukemia ,laboratory findings,
Chronic Lymphocytic Leukemia ,laboratory findings,Chronic Lymphocytic Leukemia ,laboratory findings,
Chronic Lymphocytic Leukemia ,laboratory findings,
 
DIAGNOSIS AND MANAGEMENT OF MYELOPROLIFERATIVE NEOPLASMS
DIAGNOSIS AND MANAGEMENT OF MYELOPROLIFERATIVE NEOPLASMSDIAGNOSIS AND MANAGEMENT OF MYELOPROLIFERATIVE NEOPLASMS
DIAGNOSIS AND MANAGEMENT OF MYELOPROLIFERATIVE NEOPLASMS
 
An introduction to haematological malignancies
An introduction to haematological malignanciesAn introduction to haematological malignancies
An introduction to haematological malignancies
 
ACUTE LYMPHOBLASTIC LEUKAEMIA.pptx
ACUTE LYMPHOBLASTIC LEUKAEMIA.pptxACUTE LYMPHOBLASTIC LEUKAEMIA.pptx
ACUTE LYMPHOBLASTIC LEUKAEMIA.pptx
 

More from TONY SCARIA

Mucormycosis
MucormycosisMucormycosis
Mucormycosis
TONY SCARIA
 
Phosphorus metabolism
Phosphorus metabolism Phosphorus metabolism
Phosphorus metabolism
TONY SCARIA
 
cbc Histogram
cbc Histogramcbc Histogram
cbc Histogram
TONY SCARIA
 
Osteoporosis clinical features and management
Osteoporosis clinical features and management Osteoporosis clinical features and management
Osteoporosis clinical features and management
TONY SCARIA
 
Calcium METABOLISM
Calcium METABOLISM Calcium METABOLISM
Calcium METABOLISM
TONY SCARIA
 
Magnesium metabolism
Magnesium metabolism Magnesium metabolism
Magnesium metabolism
TONY SCARIA
 
Special senses physiology revison topics
Special senses physiology revison topics Special senses physiology revison topics
Special senses physiology revison topics
TONY SCARIA
 
CSF PHYSIOLOGY ANALYSIS NORMAL AND DISEASE
CSF PHYSIOLOGY ANALYSIS NORMAL AND DISEASE CSF PHYSIOLOGY ANALYSIS NORMAL AND DISEASE
CSF PHYSIOLOGY ANALYSIS NORMAL AND DISEASE
TONY SCARIA
 
Plantar reflex
Plantar reflexPlantar reflex
Plantar reflex
TONY SCARIA
 
Dna viruses
Dna virusesDna viruses
Dna viruses
TONY SCARIA
 
Deep neck space infection ENT REVISION NOTES
Deep neck space infection ENT REVISION NOTES Deep neck space infection ENT REVISION NOTES
Deep neck space infection ENT REVISION NOTES
TONY SCARIA
 
Antirheumatic drugs &amp; anti gout drugs PHARMACOLOGY REVISION NOTES
Antirheumatic drugs &amp; anti gout drugs PHARMACOLOGY REVISION NOTES Antirheumatic drugs &amp; anti gout drugs PHARMACOLOGY REVISION NOTES
Antirheumatic drugs &amp; anti gout drugs PHARMACOLOGY REVISION NOTES
TONY SCARIA
 
Trauma to eye REVISION NOTES
Trauma to eye REVISION NOTES Trauma to eye REVISION NOTES
Trauma to eye REVISION NOTES
TONY SCARIA
 
Orbit OPHTHALMOLOGY REVISION NOTES
Orbit OPHTHALMOLOGY REVISION NOTES Orbit OPHTHALMOLOGY REVISION NOTES
Orbit OPHTHALMOLOGY REVISION NOTES
TONY SCARIA
 
Vision 2020 REVISION NOTES
Vision 2020 REVISION NOTES Vision 2020 REVISION NOTES
Vision 2020 REVISION NOTES
TONY SCARIA
 
Cataract revisionnotes ophthalmology
Cataract revisionnotes ophthalmology  Cataract revisionnotes ophthalmology
Cataract revisionnotes ophthalmology
TONY SCARIA
 
Uvea ophthalmology revision notes
Uvea ophthalmology revision notesUvea ophthalmology revision notes
Uvea ophthalmology revision notes
TONY SCARIA
 
Genetics pathology revision notes
Genetics pathology revision notes Genetics pathology revision notes
Genetics pathology revision notes
TONY SCARIA
 
Cell injury pathology revision notes
Cell injury pathology revision notes Cell injury pathology revision notes
Cell injury pathology revision notes
TONY SCARIA
 
Morphology of bacteria revision notes microbiology
Morphology of bacteria revision notes microbiologyMorphology of bacteria revision notes microbiology
Morphology of bacteria revision notes microbiology
TONY SCARIA
 

More from TONY SCARIA (20)

Mucormycosis
MucormycosisMucormycosis
Mucormycosis
 
Phosphorus metabolism
Phosphorus metabolism Phosphorus metabolism
Phosphorus metabolism
 
cbc Histogram
cbc Histogramcbc Histogram
cbc Histogram
 
Osteoporosis clinical features and management
Osteoporosis clinical features and management Osteoporosis clinical features and management
Osteoporosis clinical features and management
 
Calcium METABOLISM
Calcium METABOLISM Calcium METABOLISM
Calcium METABOLISM
 
Magnesium metabolism
Magnesium metabolism Magnesium metabolism
Magnesium metabolism
 
Special senses physiology revison topics
Special senses physiology revison topics Special senses physiology revison topics
Special senses physiology revison topics
 
CSF PHYSIOLOGY ANALYSIS NORMAL AND DISEASE
CSF PHYSIOLOGY ANALYSIS NORMAL AND DISEASE CSF PHYSIOLOGY ANALYSIS NORMAL AND DISEASE
CSF PHYSIOLOGY ANALYSIS NORMAL AND DISEASE
 
Plantar reflex
Plantar reflexPlantar reflex
Plantar reflex
 
Dna viruses
Dna virusesDna viruses
Dna viruses
 
Deep neck space infection ENT REVISION NOTES
Deep neck space infection ENT REVISION NOTES Deep neck space infection ENT REVISION NOTES
Deep neck space infection ENT REVISION NOTES
 
Antirheumatic drugs &amp; anti gout drugs PHARMACOLOGY REVISION NOTES
Antirheumatic drugs &amp; anti gout drugs PHARMACOLOGY REVISION NOTES Antirheumatic drugs &amp; anti gout drugs PHARMACOLOGY REVISION NOTES
Antirheumatic drugs &amp; anti gout drugs PHARMACOLOGY REVISION NOTES
 
Trauma to eye REVISION NOTES
Trauma to eye REVISION NOTES Trauma to eye REVISION NOTES
Trauma to eye REVISION NOTES
 
Orbit OPHTHALMOLOGY REVISION NOTES
Orbit OPHTHALMOLOGY REVISION NOTES Orbit OPHTHALMOLOGY REVISION NOTES
Orbit OPHTHALMOLOGY REVISION NOTES
 
Vision 2020 REVISION NOTES
Vision 2020 REVISION NOTES Vision 2020 REVISION NOTES
Vision 2020 REVISION NOTES
 
Cataract revisionnotes ophthalmology
Cataract revisionnotes ophthalmology  Cataract revisionnotes ophthalmology
Cataract revisionnotes ophthalmology
 
Uvea ophthalmology revision notes
Uvea ophthalmology revision notesUvea ophthalmology revision notes
Uvea ophthalmology revision notes
 
Genetics pathology revision notes
Genetics pathology revision notes Genetics pathology revision notes
Genetics pathology revision notes
 
Cell injury pathology revision notes
Cell injury pathology revision notes Cell injury pathology revision notes
Cell injury pathology revision notes
 
Morphology of bacteria revision notes microbiology
Morphology of bacteria revision notes microbiologyMorphology of bacteria revision notes microbiology
Morphology of bacteria revision notes microbiology
 

Recently uploaded

BRACHYTHERAPY OVERVIEW AND APPLICATORS
BRACHYTHERAPY OVERVIEW  AND  APPLICATORSBRACHYTHERAPY OVERVIEW  AND  APPLICATORS
BRACHYTHERAPY OVERVIEW AND APPLICATORS
Krishan Murari
 
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
bkling
 
24 Upakrama.pptx class ppt useful in all
24 Upakrama.pptx class ppt useful in all24 Upakrama.pptx class ppt useful in all
24 Upakrama.pptx class ppt useful in all
DrSathishMS1
 
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists  Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Saeid Safari
 
Couples presenting to the infertility clinic- Do they really have infertility...
Couples presenting to the infertility clinic- Do they really have infertility...Couples presenting to the infertility clinic- Do they really have infertility...
Couples presenting to the infertility clinic- Do they really have infertility...
Sujoy Dasgupta
 
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.GawadHemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
NephroTube - Dr.Gawad
 
Charaka Samhita Sutra sthana Chapter 15 Upakalpaniyaadhyaya
Charaka Samhita Sutra sthana Chapter 15 UpakalpaniyaadhyayaCharaka Samhita Sutra sthana Chapter 15 Upakalpaniyaadhyaya
Charaka Samhita Sutra sthana Chapter 15 Upakalpaniyaadhyaya
Dr KHALID B.M
 
Phone Us ❤85270-49040❤ #ℂall #gIRLS In Surat By Surat @ℂall @Girls Hotel With...
Phone Us ❤85270-49040❤ #ℂall #gIRLS In Surat By Surat @ℂall @Girls Hotel With...Phone Us ❤85270-49040❤ #ℂall #gIRLS In Surat By Surat @ℂall @Girls Hotel With...
Phone Us ❤85270-49040❤ #ℂall #gIRLS In Surat By Surat @ℂall @Girls Hotel With...
Savita Shen $i11
 
Pharynx and Clinical Correlations BY Dr.Rabia Inam Gandapore.pptx
Pharynx and Clinical Correlations BY Dr.Rabia Inam Gandapore.pptxPharynx and Clinical Correlations BY Dr.Rabia Inam Gandapore.pptx
Pharynx and Clinical Correlations BY Dr.Rabia Inam Gandapore.pptx
Dr. Rabia Inam Gandapore
 
Surat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model Safe
Surat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model SafeSurat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model Safe
Surat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model Safe
Savita Shen $i11
 
Physiology of Chemical Sensation of smell.pdf
Physiology of Chemical Sensation of smell.pdfPhysiology of Chemical Sensation of smell.pdf
Physiology of Chemical Sensation of smell.pdf
MedicoseAcademics
 
Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...
Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...
Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...
VarunMahajani
 
Novas diretrizes da OMS para os cuidados perinatais de mais qualidade
Novas diretrizes da OMS para os cuidados perinatais de mais qualidadeNovas diretrizes da OMS para os cuidados perinatais de mais qualidade
Novas diretrizes da OMS para os cuidados perinatais de mais qualidade
Prof. Marcus Renato de Carvalho
 
BENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdf
BENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdfBENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdf
BENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdf
DR SETH JOTHAM
 
Evaluation of antidepressant activity of clitoris ternatea in animals
Evaluation of antidepressant activity of clitoris ternatea in animalsEvaluation of antidepressant activity of clitoris ternatea in animals
Evaluation of antidepressant activity of clitoris ternatea in animals
Shweta
 
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
Oleg Kshivets
 
How STIs Influence the Development of Pelvic Inflammatory Disease.pptx
How STIs Influence the Development of Pelvic Inflammatory Disease.pptxHow STIs Influence the Development of Pelvic Inflammatory Disease.pptx
How STIs Influence the Development of Pelvic Inflammatory Disease.pptx
FFragrant
 
For Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #Girls
For Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #GirlsFor Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #Girls
For Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #Girls
Savita Shen $i11
 
basicmodesofventilation2022-220313203758.pdf
basicmodesofventilation2022-220313203758.pdfbasicmodesofventilation2022-220313203758.pdf
basicmodesofventilation2022-220313203758.pdf
aljamhori teaching hospital
 
Are There Any Natural Remedies To Treat Syphilis.pdf
Are There Any Natural Remedies To Treat Syphilis.pdfAre There Any Natural Remedies To Treat Syphilis.pdf
Are There Any Natural Remedies To Treat Syphilis.pdf
Little Cross Family Clinic
 

Recently uploaded (20)

BRACHYTHERAPY OVERVIEW AND APPLICATORS
BRACHYTHERAPY OVERVIEW  AND  APPLICATORSBRACHYTHERAPY OVERVIEW  AND  APPLICATORS
BRACHYTHERAPY OVERVIEW AND APPLICATORS
 
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
 
24 Upakrama.pptx class ppt useful in all
24 Upakrama.pptx class ppt useful in all24 Upakrama.pptx class ppt useful in all
24 Upakrama.pptx class ppt useful in all
 
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists  Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
 
Couples presenting to the infertility clinic- Do they really have infertility...
Couples presenting to the infertility clinic- Do they really have infertility...Couples presenting to the infertility clinic- Do they really have infertility...
Couples presenting to the infertility clinic- Do they really have infertility...
 
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.GawadHemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
 
Charaka Samhita Sutra sthana Chapter 15 Upakalpaniyaadhyaya
Charaka Samhita Sutra sthana Chapter 15 UpakalpaniyaadhyayaCharaka Samhita Sutra sthana Chapter 15 Upakalpaniyaadhyaya
Charaka Samhita Sutra sthana Chapter 15 Upakalpaniyaadhyaya
 
Phone Us ❤85270-49040❤ #ℂall #gIRLS In Surat By Surat @ℂall @Girls Hotel With...
Phone Us ❤85270-49040❤ #ℂall #gIRLS In Surat By Surat @ℂall @Girls Hotel With...Phone Us ❤85270-49040❤ #ℂall #gIRLS In Surat By Surat @ℂall @Girls Hotel With...
Phone Us ❤85270-49040❤ #ℂall #gIRLS In Surat By Surat @ℂall @Girls Hotel With...
 
Pharynx and Clinical Correlations BY Dr.Rabia Inam Gandapore.pptx
Pharynx and Clinical Correlations BY Dr.Rabia Inam Gandapore.pptxPharynx and Clinical Correlations BY Dr.Rabia Inam Gandapore.pptx
Pharynx and Clinical Correlations BY Dr.Rabia Inam Gandapore.pptx
 
Surat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model Safe
Surat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model SafeSurat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model Safe
Surat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model Safe
 
Physiology of Chemical Sensation of smell.pdf
Physiology of Chemical Sensation of smell.pdfPhysiology of Chemical Sensation of smell.pdf
Physiology of Chemical Sensation of smell.pdf
 
Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...
Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...
Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...
 
Novas diretrizes da OMS para os cuidados perinatais de mais qualidade
Novas diretrizes da OMS para os cuidados perinatais de mais qualidadeNovas diretrizes da OMS para os cuidados perinatais de mais qualidade
Novas diretrizes da OMS para os cuidados perinatais de mais qualidade
 
BENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdf
BENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdfBENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdf
BENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdf
 
Evaluation of antidepressant activity of clitoris ternatea in animals
Evaluation of antidepressant activity of clitoris ternatea in animalsEvaluation of antidepressant activity of clitoris ternatea in animals
Evaluation of antidepressant activity of clitoris ternatea in animals
 
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
 
How STIs Influence the Development of Pelvic Inflammatory Disease.pptx
How STIs Influence the Development of Pelvic Inflammatory Disease.pptxHow STIs Influence the Development of Pelvic Inflammatory Disease.pptx
How STIs Influence the Development of Pelvic Inflammatory Disease.pptx
 
For Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #Girls
For Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #GirlsFor Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #Girls
For Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #Girls
 
basicmodesofventilation2022-220313203758.pdf
basicmodesofventilation2022-220313203758.pdfbasicmodesofventilation2022-220313203758.pdf
basicmodesofventilation2022-220313203758.pdf
 
Are There Any Natural Remedies To Treat Syphilis.pdf
Are There Any Natural Remedies To Treat Syphilis.pdfAre There Any Natural Remedies To Treat Syphilis.pdf
Are There Any Natural Remedies To Treat Syphilis.pdf
 

Leukemia and lymphoma PATHOLOGY REVISION NOTES

  • 1. 22-04-2018 Leukemia and lymphoma TONY SCARIA 2010 KMC Leukemoid reaction • Persistent leucocytosis above 50000 cells /mm3 • Major causes • a/c severe infections • Severe haemorrhages • a/c hemolysis • Malignancies • Downs syndrome • Asplenia • DKA TONY SCARIA 2010 KMC
  • 3. 22-04-2018 • Immature forms present • Early mature neutrophils are seen in leukemoid reaction • Immature forms typically seen in CML • LAP score is elevated in leukemoid reaction • Depressed in CML • No orgnaomegaly • Organomegaly + in CML • Basophilia eosinophilia thrombocytosis • In CML • Absent in leukemoid reactionsTONY SCARIA 2010 KMC TONY SCARIA 2010 KMC
  • 4. 22-04-2018 • Leucocytosis is not seen in typhoid TONY SCARIA 2010 KMC TONY SCARIA 2010 KMC
  • 6. 22-04-2018 TONY SCARIA 2010 KMC • Auer rods • Most definitive sign of myeloid differentiation • Cluster of auer rods  faggot TONY SCARIA 2010 KMC
  • 8. 22-04-2018 In ALL • Cytochemical stain  PAS +ve • Dot like • Block like TONY SCARIA 2010 KMC PAS positivity is due to glycogen deposits in lymphoblast TONY SCARIA 2010 KMC
  • 9. 22-04-2018 In M6 of AML • Diffuse positivity by PAS TONY SCARIA 2010 KMC TONY SCARIA 2010 KMC
  • 10. 22-04-2018 Myeloblast with auer rods TONY SCARIA 2010 KMC TONY SCARIA 2010 KMC
  • 11. 22-04-2018 MPO positivity for granules in myelocytes TONY SCARIA 2010 KMC Non specific esterase staining for M3 M4 M5 The blasts show a strong positive reaction for non-specific esterase, as observed by the dense orange cytoplasmic staining. This reaction is positive in monocytic cells, and negative in granulocytes. TONY SCARIA 2010 KMC
  • 14. 22-04-2018 TONY SCARIA 2010 KMC • Tdt(terminal deoxytransferase ) a DNA polymerase present in Pre B ALL & Pre T ALL TONY SCARIA 2010 KMC
  • 15. 22-04-2018 Cytogenetics in Pre B ALL • B cell ALL is associated with • loss of function mutation in PAX5, E2A and EBF or • balanced t (12;21) affecting ETV6 and RUNX1 genes (normally required for B cell development). • Hyperdiploidy  MC cytogenetic change • Trisomy 4 7 & 10 • Hypoploidy • Both hypoploidy & hyperploidy are pesent in pre B ALL TONY SCARIA 2010 KMC Loss of function mutation of E2A EBF PAX5 TONY SCARIA 2010 KMC
  • 17. 22-04-2018 CD10  common ALL antigen Pre B ALL express TdT CD 10 CD 19 CD20 PAX5 TONY SCARIA 2010 KMC Pre T ALL • 15 % cases • Teenage (13 – 17 yrs of age ) in boys • Presents as a mediastinal mass in thymus • Early testicular involvement & early CNS manifestation d/t meningeal spread TONY SCARIA 2010 KMC
  • 18. 22-04-2018 Molecular patho genesis in Pre T ALL • Gain of function mutation in NOTCH 1 TONY SCARIA 2010 KMC Pre T ALL • Teenagers • Thymic involvement • Testicular involvement poor prognosis TONY SCARIA 2010 KMC
  • 19. 22-04-2018 Immunophenotype in pre T ALL • TdT • CD1 • CD2 • CD5 • CD7 TONY SCARIA 2010 KMC Good prognosis • Age 2-10 years • Female sex • white race • Peripheral blast count <10,000 • Pre B-cell phenotype(CALLA +ve) • L1 morphology • Absence of mediastinal mass • Absence of CNS involvement • Absence of testicular involvement • Hyperdiploidy (>50 chromosomes) • t(12;21) or t (9:12) • Trisomy 4,7 and 10 Bad prognosis • Age <1 year or > 10 years • Male sex • Black • Peripheral blast count >50,000 • Pre T-cell phenotype • L2 L3 morphology • Mediastinal mass • CNS involvement • Testicular involvement • Pseudodiploidy or • t (9;22) (Philadelphia chromosome) or t (8;14) or t (4;11) TONY SCARIA 2010 KMC
  • 22. 22-04-2018 AML • Adults 15 to 40 years • Acquired oncogenic mutation • Accumalation of immature blast cells in marrow •  marrow failure  pancytopenia TONY SCARIA 2010 KMC Etiology • Environmental • Chemicals like benzene & alkylating agents • Ionizing radiation • Smoking • Hereditary factors • Downs syndrome • Fanconis anemia • AT • Blooms syndrome • Turner syndrome TONY SCARIA 2010 KMC
  • 23. 22-04-2018 TONY SCARIA 2010 KMC Haematological conditions predisposing to AML • CML with blast crisis • Myeloproliferative disorder • Myelodysplasia • PNH • Aplastic anemia TONY SCARIA 2010 KMC
  • 24. 22-04-2018 • Diagnosis • Blast cell count > 20 % or more in peripheral blood or bone marrow TONY SCARIA 2010 KMC TONY SCARIA 2010 KMC
  • 26. 22-04-2018 AML with recurrent genetic abnormalities • AML t(8:21) RUNx1 fusion gene (M2) • AML inv (16) M4E0 • Acute promyelocytic leukemia t (15:17) M3 • AML t 11q 23 MLL fusion gene  bad prognosis • AML with normal cytogenetics & mutated NPM (nucleophosmin) TONY SCARIA 2010 KMC AML therapy related • Alkylating therapy  MDS like cytogenetics changes (5q-7q-)latency of 2-8 years • Following of topoisomerase II inhibitors 1-3 yrs of latency TONY SCARIA 2010 KMC
  • 27. 22-04-2018 AML with MDS like features • Dysplastic changes & cytogenetics of 5q 7q 20 q TONY SCARIA 2010 KMC TONY SCARIA 2010 KMC
  • 28. 22-04-2018 TONY SCARIA 2010 KMC AML M0 • Difficult to diagnose • No maturation • MPO /PAS –ve TONY SCARIA 2010 KMC
  • 29. 22-04-2018 AML M3 t(15:17) • Multiple auer rods (Faggot cells) • Heavily granulated  strong MPO+positivity • Granules contain procoagulant DIC • Common in young female DIC manifest as menorrhagia TONY SCARIA 2010 KMC AML M3 TONY SCARIA 2010 KMC
  • 30. 22-04-2018 AML M5  gingival hyperplasia TONY SCARIA 2010 KMC pancytopenia TONY SCARIA 2010 KMC
  • 31. 22-04-2018 Criteria for remission in AML • Platelet count > 1lakh • Neutrophil >1500 • Bone marrow blast <5 % and absent auer rods • Absence of extra medullary lesion TONY SCARIA 2010 KMC Chloroma TONY SCARIA 2010 KMC
  • 32. 22-04-2018 Chloroma / myeloid sarcoma /granulocytic sarcoma • Solid tumour with myeloblast • Extramedullary manifestation of AML • May be hidden manifestation of AML (common in M2 / monocytic (M3orM4) • Follow up for development of AML with bone marrow transplantation • Mc seen in skin of orbit & periorbital tissue TONY SCARIA 2010 KMC TONY SCARIA 2010 KMC
  • 33. 22-04-2018 Arbinskov cells are monocytes in chloroma TONY SCARIA 2010 KMC Markers for granulocytic sarcoma • CD 33 • CD 43 • CD 117 • Myeloperoxidase • Lysozyme TONY SCARIA 2010 KMC
  • 34. 22-04-2018 CLL TONY SCARIA 2010 KMC CLL • Absolute lymphocyte count > 5000 cell/mm3 • Males are more commonly affected • > 60 yrs • Most common lymphoma in western world TONY SCARIA 2010 KMC
  • 35. 22-04-2018 CF Symptoms • Fatigue (commonest presentation) • Infections d/t hypogammaglobulinemia Signs • Lymphadenopathy • Initially cervical  generalised • Hepatosplenomegaly • TONY SCARIA 2010 KMC • Both cell types are affected • B cell types & T cell types (B cell >> t cell) • Hypogammaglobulinemia + • Auto Ab against RBC  AIHA TONY SCARIA 2010 KMC
  • 36. 22-04-2018 • diagnostic criteria for CLL are: • • Peripheral blood lymphocyte count >5000 cells/mm3with <55% cells being atypical. • • Bone marrow aspirate showing >30 % lymphocytes TONY SCARIA 2010 KMC • deletion of 13q • commonest and has good prognosis • Tumour suppressor genes miR15 a & miR16- 1+ on chr 13 • Deletion 11q • trisomy 12q and • deletion of 17p have poor prognosis TONY SCARIA 2010 KMC
  • 37. 22-04-2018 • IOC • Flowcytometry • Used to detect lymphocytosis & immunophenotyping • Immunophenotyping} CD 5 CD23 CD19 cD20 TONY SCARIA 2010 KMC Peripheral smear • Smudge cells /parachute cells/basket cells • Slide artefact • Tumour cells appear as fragile disrupted tumour cells formation • Due to lack of vimentin (cytoskeletal protein required for rigidity & integrity of cells Smudge cells are also seen in infections CLL a/c leukemia TONY SCARIA 2010 KMC
  • 38. 22-04-2018 Lymph node biopsy • Large mitotic cells known as prolymphocytes • Divide & form diagnostic proliferation centres • Distortion of architecture • Diffue effacement of LN architecture • Commonest • d/t proliferation cenrtres • Pseudofollicular pattern • Rare TONY SCARIA 2010 KMC Diffuse effacement of LN TONY SCARIA 2010 KMC
  • 39. 22-04-2018 Basket cells in CLL TONY SCARIA 2010 KMC Bad prognosis • Expression of ZAP 70 • Presence of NOTCH 1 mutation • Deletions of 11q 17 p or trisomy 12 TONY SCARIA 2010 KMC
  • 40. 22-04-2018 ZAP 70 a/w poor prognosis TONY SCARIA 2010 KMC ZAP 70 is a/w drug resistance TONY SCARIA 2010 KMC
  • 41. 22-04-2018 TONY SCARIA 2010 KMC Transformations in CLL • Prolymphocytic transformation • Cb worsening of cytopenia increasing splenomegaly & large number of prolymphocytes in circulation • Richter syndrome TONY SCARIA 2010 KMC
  • 42. 22-04-2018 Richter syndrome • Transformation of CLL in to DLBL • Presents as rapidly enlarging mass in spleen or LN TONY SCARIA 2010 KMC Myelodysplastic syndrome TONY SCARIA 2010 KMC
  • 43. 22-04-2018 Myelodysplastic syndrome • Clonal stem cell disorder • Ineffective haematopoesis • Transformation to AML • DD of megaloblastic anemia TONY SCARIA 2010 KMC • 1. Primary MDS – Develops slowly usually after 50 years of age. • 2. Secondary or Therapy related MDS (t-MDS) – • Usually 2 to 8 years after toxic drug or radiation exposure. The secondary MDS gets transformed to AML most frequently and so has a poorer prognosis. TONY SCARIA 2010 KMC
  • 45. 22-04-2018 Erythroid lineage shows ringed sideroblast • Iron laden mitochondria in perinuclear area • Visible as blue granules in Prussian blue staining • Also ssen in • MDS • Pb poisoning • Sideroblastic anemia TONY SCARIA 2010 KMC TONY SCARIA 2010 KMC
  • 46. 22-04-2018 MDS is cb DOHLE bodies in granulocytic lineage • Damaged RER • Also seen in MDS • Sepsis • Chediak higashi syndrome TONY SCARIA 2010 KMC Granulocytic lineage also has pseudo pelger huet anomaly • Neutrophil with bilobed nuclei • MDS • AML with dysplastic maturation • CML during accelerated phase TONY SCARIA 2010 KMC
  • 47. 22-04-2018 Megakaryocyte lineage  pawn ball appearance • Either a single nuclear lobe or multiple separate nuclei TONY SCARIA 2010 KMC TONY SCARIA 2010 KMC
  • 48. 22-04-2018 TONY SCARIA 2010 KMC Rx • erythropoetin • G CSF • Lenalidomide • Azacytidine • antimetabolite that inhibits DNA methylation • BM transplantation TONY SCARIA 2010 KMC
  • 49. 22-04-2018 Myeloproliferative disorders • CML • Polycythemia vera • Essential thrombocythemia • c/c idiopathic myelofibrosis • c./c neutrophilic leukemia • c/c eosinophilous leukemia TONY SCARIA 2010 KMC Common feature of MPD • Increased proliferative drive in the marrow • Extra medullary haematopoesis • Spent phase transformation • Cb marrow fibrosis & peripheral blood cytopenia • a./c leukemia transformation TONY SCARIA 2010 KMC
  • 50. 22-04-2018 • MPD may undergo transformation in to a/c leukemia • Diagnosed by BM examination • Blood count • To determine proliferating cell line • Marrow infiltration decrease in normal cells TONY SCARIA 2010 KMC CML TONY SCARIA 2010 KMC
  • 51. 22-04-2018 Philadelphia chromosome / reciprocal translocation / Chr t (9:22) TONY SCARIA 2010 KMC • LAP score will be elevated in accelerate & blast crisis • But decreased in chronic phase TONY SCARIA 2010 KMC
  • 52. 22-04-2018 P/S in CML • Leucocytosis (>1,00,000) • Blast count <10 % • Consist of neutrophils (band forms metamyelocytes & myocytes) eosinophils & basophils TONY SCARIA 2010 KMC TONY SCARIA 2010 KMC
  • 53. 22-04-2018 TONY SCARIA 2010 KMC • Pseudo gaucher cells with wrinkled cytoplasm TONY SCARIA 2010 KMC
  • 55. 22-04-2018 TONY SCARIA 2010 KMC Prognostic markers • Soklal index • Age • Blast (circulating) • Cytogenetic changes • Platelet count • Spleen size • Hasford index • Age • Blast (circulating ) • Basophils & eosinophils • Platelet count • Spleen size TONY SCARIA 2010 KMC
  • 56. 22-04-2018 TONY SCARIA 2010 KMC Rx • Allogenic or syngenic bone marrow transplant • Patients in early chronic phase • Imatinib (also used in treatment of GIST) • DOC • Dasatinib or IFN alpha • Rx of accelerated or blast phase • Hydroxyurea • Arsenic can also be used • Leukapheresis & splenectomyTONY SCARIA 2010 KMC
  • 57. 22-04-2018 TONY SCARIA 2010 KMC Polycythemia rubra • the most common of the chronic myeloproliferative disorders • characterized by the increased number of erythroid, granulocytic and megakaryocytic cells (panmyelosis) • Mutation in JAK 2 tyrosine kinase pathway • Can be • Polycythemia rubra vera (primary polycythemia) • Secondary polycythemia TONY SCARIA 2010 KMC
  • 58. 22-04-2018 TONY SCARIA 2010 KMC • Increased red cell mass • Microcytosis with erythrocytosis • Hb >18.5 in in males 16.5 in females • Hyperviscosity stagnation of blood flow • Thrombosis • Deoxygenation  cyanosis TONY SCARIA 2010 KMC
  • 59. 22-04-2018 • Extra medullary hematopoesis organomegaly • Bone marrow  trilineage hyperplasia • High cell turn over  hyperuricemia • Platelet dysfunction bleeding & thrombotic events • Basophilia  histamine release  aquagenic pruritus & peptic ulcer TONY SCARIA 2010 KMC • Erythropoietin is elevated in secondary polycythemia • Decreased or normal in PCV TONY SCARIA 2010 KMC
  • 60. 22-04-2018 • Causes of secondary polycythemia • Hypoxia • High altitude • Lung Ca • Smoking • COPD • Congenital cyanotic heart ds • Secondary tumours producing erythropoietin • Renal cyst • Hypernephroma • Hydronephrosis • Renal A stenosis • Cerbellar haemangioblastoma • Hepatoma • Pheochromocytoma TONY SCARIA 2010 KMC Features of polycythemia • Increased levels of vitamin B12 • Microcytosis with erythrocytosis • Increased LAP score • Decreased ESR • Decreased ESR • Polycythemia • Afibroginemia • CHF • Microcytosis with erythrocytosis • c/c hypoxia • PCV • Beta thalassemia TONY SCARIA 2010 KMC
  • 61. 22-04-2018 • Rx • venesection • Anagrelide • Decreases platelet production • CTx • Hydroxyurea • Radioactive phosphorous TONY SCARIA 2010 KMC • Spurious / low plasma volume polycythemia • Gaisbock syndrome • Decrease in plasma volume  relative increase in red cell count Hb haematocrit TONY SCARIA 2010 KMC
  • 62. 22-04-2018 TONY SCARIA 2010 KMC Essential thrombocythemia TONY SCARIA 2010 KMC
  • 63. 22-04-2018 Diagnostic criteria • Sustained platelet count >4.5 lakhs/mm3 • BM biopsy • Megakaryocyte proliferation with large & mature morphology • Not meeting WHO critera for CML PV PMF MDS • Demonstration of JAK2 mutation or other clonal marker • No evidence of reactive thrombocytosis TONY SCARIA 2010 KMC TONY SCARIA 2010 KMC
  • 64. 22-04-2018 Rx • Aspirin low dose 60mg/day • Busulfan /hydroxyurea • Interferon alpha • Radioactive phosphorous • Anagrelide TONY SCARIA 2010 KMC TONY SCARIA 2010 KMC
  • 65. 22-04-2018 Primary myelofibrosis TONY SCARIA 2010 KMC Tear drop cells + leucoerythroblastic picture TONY SCARIA 2010 KMC
  • 66. 22-04-2018 • BM biopsy for marrow fibrosis • Initially hypercellular • Then becomes hypocellular • Abnormal megakaryocytes with unusual nuclear shapes • Dilated marrow sinusoids TONY SCARIA 2010 KMC Silver staining for reticulin TONY SCARIA 2010 KMC
  • 67. 22-04-2018 Staining with masons trichrome S TONY SCARIA 2010 KMC TONY SCARIA 2010 KMC
  • 68. 22-04-2018 Myeloproliferative / myelodysplastic neoplasm TONY SCARIA 2010 KMC • Clonal myeloid disorders • Both dysplastic & proliferative features not classified in MDS /MPN • Chronic myelomonocytic leukemia (CMML) • Juvenile myelomonocytic leukemia • Atypical CML TONY SCARIA 2010 KMC
  • 69. 22-04-2018 CMML • Most common MDS MPN • Absence of Philadelphia chromosome TONY SCARIA 2010 KMC TONY SCARIA 2010 KMC
  • 70. 22-04-2018 JMML • children <2yrs • 2% child hood leukemia • Children with NF1 are at increased risk for development of JMML TONY SCARIA 2010 KMC Major criteria (all the three) • Absence of Ph chromosome • Peripheral monocytes greater than 1*10^9 /L • Less than 20 % blast Minor criteria • HbF raised • Immature granulocytes in peripheral blood • WBC count > 1*10^9 /L • Clonal chromosomal abnormality (monosomy 7) • GM CSF hypersensitivity of myeloid progenitors in vitroTONY SCARIA 2010 KMC
  • 71. 22-04-2018 Atypical CML TONY SCARIA 2010 KMC • Rx • Very aggressive • But chemosensitive TONY SCARIA 2010 KMC
  • 72. 22-04-2018 Peripheral B cell neoplasm TONY SCARIA 2010 KMC Basics TONY SCARIA 2010 KMC
  • 73. 22-04-2018 TONY SCARIA 2010 KMC Mantle cell lymphoma • B cell lymphoma • Arises from naive B cells • Males of 50 – 60 yrs • Presents as painless lymphadenopathy TONY SCARIA 2010 KMC
  • 74. 22-04-2018 T(11:14) is seen in mantle zone lymphoma Bcl 1 = cyclin D! TONY SCARIA 2010 KMC • Express cyclin D1 (= Bcl1) & surface Ig • CD 5+ CD23-ve (CD5 +ve CD 23 +ve in CLL) • Charcteristic pattern of spread is also known as LYMPHOMATOID POLYPOSIS LYMPHOMATOID POLYPOSIS TONY SCARIA 2010 KMC
  • 75. 22-04-2018 Diffuse large b cell lymphoma • Most common NHL • Most malignant  WORST prognosis • Affects older individual Medial age of 60 years • mature B cell tumour TONY SCARIA 2010 KMC Immunophenotyping of DLBL • CD 19 CD20 • Variable expression of germinal center markers such as Bcl-6 or CD10 • Surface Ig+ TONY SCARIA 2010 KMC
  • 76. 22-04-2018 Cytogenetics of DLBL • Translocations involving Bcl-6 • Translocation t(14:18) overexpression of Bcl-2  decreased apoptosis • MYC tranlocatins TONY SCARIA 2010 KMC Special types of DLBL • Immunodeficiency associated large B cell lymphoma • In severe T cell immunodeficiency like HIV & bone marrow transplantation • Neoplastic cells are latently infected with EBV • Restoration of T cell immunity  regression of tumour • Primary effusion lymphoma • Seen in elderly • As malignant pleural or ascetic effusion • Tumour cells  anaplastic  lack T or B cell markers • Tumour cells are infected with human Kaposi sarcoma herpes virus TONY SCARIA 2010 KMC
  • 77. 22-04-2018 Follicular lymphoma • B cell lymphoma arising from germinal centre • LN biopsy • Centrocytes • Small cells with cleaved nuclear contours & scanty cytoplasm (buttock cells ) • Centroblast • Large cells with open nuclear chromatin several nucleoli modest amount of cytoplasm TONY SCARIA 2010 KMC TONY SCARIA 2010 KMC
  • 78. 22-04-2018 • BM biopsy  paratrabecular lymphoid aggregates in follicular lymphoma TONY SCARIA 2010 KMC Translocation of 14 : 18  follicular lymphoma Over expression of Bcl2 30-50 % transform in to DLBCL TONY SCARIA 2010 KMC
  • 79. 22-04-2018 Cytogenetics of follicular lymphoma • CD19 CD20 • Arising from germinal centre Bcl -6 & CD10 TONY SCARIA 2010 KMC Marginal zone lymphoma  MALToma • Mucosa associated lymphoid issue  MALToma • Resembles normal marginal zone B cell • Most common site is stomach • 3 characteristic features • a/w c/c inflammatory conditions • like psojgrens syndrome • Hashimotos thyroiditis • Stomach H pylori infection • Remain localized for long periods • Regress on removal of inciting stimulus • Upregulation of Bcl10 or MALT1 TONY SCARIA 2010 KMC
  • 80. 22-04-2018 TONY SCARIA 2010 KMC Cytogenetics a/w MALToma • t(11:18)resistant to Ctx • T(14:18) • T(1:14) TONY SCARIA 2010 KMC
  • 81. 22-04-2018 Burkitts lymphoma • Peripheral B cell neoplasm • ALL L3 • most common cause of tumour lysis syndrome TONY SCARIA 2010 KMC T(8:14)in burkitts lymphoma TONY SCARIA 2010 KMC
  • 82. 22-04-2018 TONY SCARIA 2010 KMC C-myc gene on chromosome 8 TONY SCARIA 2010 KMC
  • 83. 22-04-2018 3 categories of burkitts lymphoma • African endemic • Sporadic (non endemic) • HIV associated aggressive TONY SCARIA 2010 KMC African endemic • Most commonly affects face /mandible • Children / young adults • All cases will be latently infected with EBV TONY SCARIA 2010 KMC
  • 84. 22-04-2018 Sporadic (nonendemic ) BL • Seen in children /young adults • Presents as Illeocaecal / peritoneal mass • 15 – 20 % latently infected with EBV TONY SCARIA 2010 KMC HIV associated aggressive lymphomas • 25 % of the patients are latently infected by EBV TONY SCARIA 2010 KMC
  • 85. 22-04-2018 Starry sky pattern due to apoptotic tumour cell laden foamy macrophages TONY SCARIA 2010 KMC TONY SCARIA 2010 KMC
  • 86. 22-04-2018 • Immunophenotyping reveals the cells expressing • bcl-6 protein, • surface Ig, CD19, CD20 and • CD10 (CALLA) TONY SCARIA 2010 KMC TONY SCARIA 2010 KMC
  • 87. 22-04-2018 Immunostaining of burkitts lymphoma • Ki 67 • MIB1 • PCNA • AgNOR TONY SCARIA 2010 KMC Hairy cell leukemia TONY SCARIA 2010 KMC
  • 88. 22-04-2018 Hairy cell leukemia • Middle aged • Male (M:F=6:1) • Indolent course • Peripheral B cell neoplasm TONY SCARIA 2010 KMC • Hairy cells are best seen by phase contrast microscopy TONY SCARIA 2010 KMC
  • 89. 22-04-2018 Triad of HCL • Pancytopenia • Massive splenomegaly (no lymph node enlargement) • Most common presentation • Vasculitis like syndrome (erythema nodosum) TONY SCARIA 2010 KMC TRAP positivity TONY SCARIA 2010 KMC
  • 90. 22-04-2018 TONY SCARIA 2010 KMC Fried egg appearance of hairy cell in bone marrow /honey comb appearance TONY SCARIA 2010 KMC
  • 91. 22-04-2018 Immunophenotyping • Pan B markers • CD 19 CD 20 surface Ig • Monocyte specific • CD11c • CD25 • Characteristically expression of hairy cell leukemia • CD103 • T cell specific • Annexin A1 • Best & specific TONY SCARIA 2010 KMC TONY SCARIA 2010 KMC
  • 92. 22-04-2018 • Rx • Chemosensitive • Cladiribine & deoxycoformycin • Splenectomy for severe pancytopenia • Good prognosis TONY SCARIA 2010 KMC Peripheral T cell neoplasm TONY SCARIA 2010 KMC
  • 93. 22-04-2018 Mycosis fungoides • Tumour of CD4 + helper T cells • Epidermotropism • d/t cutaneous localizaition of tumour cells • Chemokine receptors CCR4 & CCR10 TONY SCARIA 2010 KMC Pautriers microabscess TONY SCARIA 2010 KMC
  • 94. 22-04-2018 TONY SCARIA 2010 KMC Cerebriform nuclei TONY SCARIA 2010 KMC
  • 95. 22-04-2018 TONY SCARIA 2010 KMC Mycosis fungoides (cutaneous T cell lymphoma) • NHL presenting with skin infiltration • MC primary cutaneous lymphoma of T cell origin • In middle aged males and blacks • C/F • Pruritic localised erythematous plaques on trunk > 5 cm TONY SCARIA 2010 KMC
  • 96. 22-04-2018 Pautrier microabscess is characteristic of MF. pleomorhic lymphocytes as clusters in epidermis TONY SCARIA 2010 KMC Sezary syndrome • Advanced MF with lypmpadenpathy and visceral spread • Generalised exfoliative erythroderma • Circulating atypical lymphocytes(sezrry cells) • Detected by T – cell rearrangement test TONY SCARIA 2010 KMC
  • 97. 22-04-2018 • Mycosis fungoides is an indolent cutaneous T-cell lymphoma (indolent course) but is inevitably fatal (not easily amenable to treatment), except for patients in stage I. • Localised d/s • Topical N2 mustard, corticosteroids,bexarotene PUVA • Advanced • PUVA+ oral retinoids • Electron beam therapy • denileukin • Romidepsin • Vorinostat • Alemtuzumab(anti – CD 52 Ab) • histone deacetylase inhibitors TONY SCARIA 2010 KMC • It has 3 phases • Inflammatory premycotic phase • Plaque phase • Tumor phase TONY SCARIA 2010 KMC
  • 98. 22-04-2018 TONY SCARIA 2010 KMC sezary syndrome • Leukemic phase of disease • Sezry cells in peripheral smear • Cerebriform nuclei • Generalized exfoliative erythroderma TONY SCARIA 2010 KMC
  • 99. 22-04-2018 Large granular lymphocytic leukemia • Occuring mainly in adults • Neutropenia anemia • Pure red cell aplasia  anemia • a/w • Rheumatological disorder • feltys syndrome • RA • Splenomegaly • Neutropenia TONY SCARIA 2010 KMC Adult T cell leukemia • Neoplasm of CD4 + T cells • Endemicity • CF • Lymhadenopathy • HSM • Skin lesions TONY SCARIA 2010 KMC
  • 100. 22-04-2018 HTLV 1 tax gene TONY SCARIA 2010 KMC TONY SCARIA 2010 KMC
  • 101. 22-04-2018 • Clover leaf cells / flower cells TONY SCARIA 2010 KMC Anaplastic large cell lymphoma TONY SCARIA 2010 KMC
  • 103. 22-04-2018 NK cells TONY SCARIA 2010 KMC NK cell granuloma • Extranodal Midline • Destructive nasopharyngeal mass • Invade vessels  ischemic necrosis • EBV associated • CD 16 & 56 • CD 3 –ve TONY SCARIA 2010 KMC
  • 104. 22-04-2018 Miscellaneous TONY SCARIA 2010 KMC Post transplantation lympho proliferative ds • Diverse group of abnormal lymphoid growth • Consisting of both hyperplasia & neoplasia • Majority are Bcell origin • Rarely t cell or NK cell TONY SCARIA 2010 KMC
  • 106. 22-04-2018 TONY SCARIA 2010 KMC • Arises single node and spreads by contiguous spread • Reed sternberg cells • derived from the germinal center B cell • induces the accumulation of reactive lymphocytes, macrophages and granulocytes • Neoplastic giant cell • Owl eye appearance • Also seen in IMN • NHL (immunoblastic NHL) • Carcinoma & sarcoma TONY SCARIA 2010 KMC
  • 108. 22-04-2018 • “owl-eye” appearance • due to the presence of symmetric (mirror image) bilobed nucleus with prominent nucleoli surrounded by clear space • PAX 5 is best marker for reed Sternberg cell TONY SCARIA 2010 KMC TONY SCARIA 2010 KMC
  • 109. 22-04-2018 • Classical reed Sternberg cells • Express PAX5 CD15 & CD30 • Lymphohistiocytic variant • Will express germinal center B cells (CD20 & Bcl 6) TONY SCARIA 2010 KMC TONY SCARIA 2010 KMC
  • 111. 22-04-2018 NODULAR SCLEROSIS TYPE • MOST COMMON IN WORLD • abundant collagen + • Mediatinal involvement  common TONY SCARIA 2010 KMC TONY SCARIA 2010 KMC
  • 112. 22-04-2018 Mixed cellularity • Most common in developing countries • Biphasic incidence Young age >55 years TONY SCARIA 2010 KMC TONY SCARIA 2010 KMC
  • 113. 22-04-2018 Lymphocyte rich histiocytes TONY SCARIA 2010 KMC Lymphocyte depleted • Lymphocyte depleted • Mummified RS cells TONY SCARIA 2010 KMC
  • 114. 22-04-2018 Lymphocyte predominant • Popcorn cell • L&H variant • fluffy, lobulated nucleus having fine chromatin and small nucleoli. TONY SCARIA 2010 KMC TONY SCARIA 2010 KMC
  • 115. 22-04-2018 TONY SCARIA 2010 KMC CF of hodgkins lymphoma • Alcohol increases symptoms • Pel ebstein fever • Fever which cyclically increase in one or two weeks • Painless rubbery enlargement of LN • Paraneoplastic syndrome in HL • Secondary amyloidosis (AA) • Alchol induced pain in LN TONY SCARIA 2010 KMC
  • 116. 22-04-2018 Adverse prognostic factors • Age > 45 yrs • Male • Hb <10.5gm/dL • Leucocyte count >15000 • Lymphocytopenia • Absolute lymphocyte count <600/ul • Lymphocyte <8 % • Serum albumin <4gm/dL • Stage IV TONY SCARIA 2010 KMC TONY SCARIA 2010 KMC
  • 117. 22-04-2018 Best prognosis • Lymphocyte predominant >> nodular sclerosis TONY SCARIA 2010 KMC Bad prognosis • Mediastinal involvement • Lymphocyte depletion type • Systemic symptoms TONY SCARIA 2010 KMC
  • 118. 22-04-2018 Ann arbor staging TONY SCARIA 2010 KMC Rx • ABVD is more effective than MOPP TONY SCARIA 2010 KMC
  • 119. 22-04-2018 IMN • Atypical lymphocytes in peripheral smear • DOWNEY CELLS • Atypical lymphocytes  activated CD8 –T (cytotoxic) cells • Ballerina skirt appearance TONY SCARIA 2010 KMC PLASMA CELL NEOPLASMS TONY SCARIA 2010 KMC
  • 120. 22-04-2018 Plasma cell neoplasm • Neoplasm of terminally differentiated B cells TONY SCARIA 2010 KMC TONY SCARIA 2010 KMC
  • 121. 22-04-2018 Multiple myeloma • Clonal plasma cells >10 % on BM biopsy • Or in any quantity in biopsy from other tissues  plamcocytoma • Monoclonal protein in either serum or urine • Except in cases of true non secretory myeloma • Evidence of end organ damage • CRAB • Calcium elevation >11.5 Hypercalcemia • Renal insufficiency (s creatinine >2mg/dl • Anemia (haemoglobin <10gm/dl) • Bone lesions (lytic lesion/osteoporosis with compression#) TONY SCARIA 2010 KMC Plasma cell leukemia TONY SCARIA 2010 KMC
  • 122. 22-04-2018 • Multiple myeloma • Age group 65 and 70 yrs TONY SCARIA 2010 KMC TONY SCARIA 2010 KMC
  • 123. 22-04-2018 Radiographically • Punched out lesions will be seen • Vertebrae is most commonly involved • Vertebra>>ribs>>skull>.pelvis >>femur >> clavicle TONY SCARIA 2010 KMC Hypercalcemia • Hypercalcemia metasatic calcification TONY SCARIA 2010 KMC
  • 125. 22-04-2018 Immunity • Hypogammaglobulinemia  decreased humoral immunity • Cellular immunity is normal TONY SCARIA 2010 KMC Hyperviscosity syndrome TONY SCARIA 2010 KMC
  • 126. 22-04-2018 TONY SCARIA 2010 KMC Old diagnostic criteria TONY SCARIA 2010 KMC
  • 127. 22-04-2018 • Definitive diagnosis is with bone marrow examination TONY SCARIA 2010 KMC Marked rouleaux formation d/t M proteins TONY SCARIA 2010 KMC
  • 128. 22-04-2018 Plasma cells TONY SCARIA 2010 KMC TONY SCARIA 2010 KMC
  • 129. 22-04-2018 FlAme cells (IgA myeloma) TONY SCARIA 2010 KMC Russel bodies are inclusions in Endoplasmic reticulum TONY SCARIA 2010 KMC
  • 130. 22-04-2018 Mott cells  multiple russel bodies TONY SCARIA 2010 KMC TONY SCARIA 2010 KMC
  • 131. 22-04-2018 Complications of multiple myeloma • Systemic amyloidosis • Hyperviscosity syndrome • Renal failure • Hypercalcemia • Spinal cord compression TONY SCARIA 2010 KMC TONY SCARIA 2010 KMC
  • 133. 22-04-2018 Poor prognostic factors for multiple myeloma • Serum β2 macroglobulin >6mg/dl • Best prognostic marker • CRP > 6mg/dl • Presence of plasmablastic morphology • Bone marrow biopsy  diffuse pattern & prominent angiogenesis • Serum LDH  raised • Serum creatinine > 2mg/dl • Plasma cell labelling index > 3 % • Cytogenetics • Deletion of 13q 11p • Monosomy 13 • Hypodiploidy TONY SCARIA 2010 KMC In multiple myeloma • Anion gap is less than normal • Bcz M protein is cationic  leads to retention of chloride TONY SCARIA 2010 KMC
  • 134. 22-04-2018 Rx • Thalidomide • Leflunomide • Bortezomib  proteasome inhibitor TONY SCARIA 2010 KMC • Plasma cell leukemia • Plasma cells more than 20 % of cells • Absolute plasma cell count of more than 2000cells /mm3 TONY SCARIA 2010 KMC
  • 135. 22-04-2018 • Nonsecretory myeloma • No M band in serum or urine • All other symptoms of MM+ • Rare TONY SCARIA 2010 KMC Waldenstroms macroglobulinemia • B cell neoplasm • Affecting 60 -70 yrs • No bone destructin TONY SCARIA 2010 KMC
  • 137. 22-04-2018 MGUS • presence of M spike without associated disease of the B cells. MGUS is the • commonest cause of monoclonal gammopathy. Around 1% of the patients with MGUS progress to develop multiple myeloma per year. It is usually a diagnosis of exclusion. • Patients of MGUS have less than 3 g/dL of monoclonal protein in the serum and no Bence Jones proteinuria • Normal calcium • Rx • Symptomatic • Follow up TONY SCARIA 2010 KMC Heavy chain disease TONY SCARIA 2010 KMC
  • 139. 22-04-2018 • Cleaved nucleus • Several granules in cytoplasm  BIRBECK granules TONY SCARIA 2010 KMC TONY SCARIA 2010 KMC
  • 140. 22-04-2018 Clinicopathological entities of LCH • Letterer – siwe disease • Multifocal multisystem • Aggressive systemic disorder occurring before 2 yrs of age • Presents like seborrheic dermatitis • Bone destruction involving all bones of body • Eosinophilic granuloma • Unifocal & multifocal unisystem • Mc presentation is calvarial skull defect • Hand schuller Christian syndrome • Calvarial bone defects • Diabetes insipidus • Exophthalmos • Pulmonary lan TONY SCARIA 2010 KMC TONY SCARIA 2010 KMC
  • 142. 22-04-2018 Flow cytometry TONY SCARIA 2010 KMC TONY SCARIA 2010 KMC
  • 144. 22-04-2018 Forward scatter • To determine cell size TONY SCARIA 2010 KMC Side scatter • For density of cell (granularity vacuoles membrane size ) • Granulocytes & monocytes have more granularity  hence more scattering TONY SCARIA 2010 KMC
  • 145. 22-04-2018 • Pan-B cell markers are CD19, 20 and 21. CD21 is also acts as the receptor of EBV. TONY SCARIA 2010 KMC Clinical uses of flow cytometry • Diagnosis of PNH • Reticulocyte enumeration • Leukemia & lymphoma phenotyping • transplant rejection • Lymphocytosis TONY SCARIA 2010 KMC
  • 147. 22-04-2018 Massive splenomegaly • CML • Idioathic myelofibrosis • Gauchers ds • Hairy cell leukemia • Tropical splenomegaly • Malaria • Hypersplenism TONY SCARIA 2010 KMC TONY SCARIA 2010 KMC
  • 148. 22-04-2018 Digeorge syndrome  T cell deficiency TONY SCARIA 2010 KMC Microdeletion @ 22q11.2  digeorge syndrome TONY SCARIA 2010 KMC
  • 151. 22-04-2018 Alder reily anomaly • In mucopolysacharidose • AR  inherited MPS • Mucopysaccharidoses TONY SCARIA 2010 KMC TONY SCARIA 2010 KMC
  • 152. 22-04-2018 May hegglin anomaly • AD • Associated with macrothrombocytes • Giant platelets with thrombocytopenia TONY SCARIA 2010 KMC TONY SCARIA 2010 KMC
  • 153. 22-04-2018 TONY SCARIA 2010 KMC Kikuchis disease • Necrotising histiocytic lymphadenitis TONY SCARIA 2010 KMC
  • 154. 22-04-2018 Kimuras disease • Eosinophilic lymphadenitis TONY SCARIA 2010 KMC • The LAP score is usually decreased in chronic myelogenous leukemia and paroxysmal nocturnal hemoglobinuria, while it is increased in leukemoid reaction and polycythemia vera. TONY SCARIA 2010 KMC